<SEC-DOCUMENT>0001213900-25-085657.txt : 20250908
<SEC-HEADER>0001213900-25-085657.hdr.sgml : 20250908
<ACCEPTANCE-DATETIME>20250908173118
ACCESSION NUMBER:		0001213900-25-085657
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250902
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250908
DATE AS OF CHANGE:		20250908

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brag House Holdings, Inc.
		CENTRAL INDEX KEY:			0001903595
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42525
		FILM NUMBER:		251301048

	BUSINESS ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
		BUSINESS PHONE:		413-398-2845

	MAIL ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0256428-8k_brag.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:TBH="http://braghouse.com/20250902">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_TBH_braghouse.com_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250902_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001903595 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001903595</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tbh-20250902.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903595</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-02</xbrli:startDate>
        <xbrli:endDate>2025-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20250902__20250902_zfzEYXxm5SCk"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_907_edei--DocumentPeriodEndDate_c20250902__20250902_zajcpzxvUFjc"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 2, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityRegistrantName_c20250902__20250902_zvkAgC0Cviok"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000011" name="dei:EntityRegistrantName">Brag House Holdings, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250902__20250902_zprIGIZJUZ6l"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_90A_edei--EntityFileNumber_c20250902__20250902_zv0tuznlvGe8"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000013" name="dei:EntityFileNumber">001-42525</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250902__20250902_zYdNPZCW94Le"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">87-4032622</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20250902__20250902_zyL48COTOyaa"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000015" name="dei:EntityAddressAddressLine1">45 Park Street</ix:nonNumeric></span>,<br/>
<span id="xdx_90C_edei--EntityAddressCityOrTown_c20250902__20250902_zREt2PR9Snua"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000016" name="dei:EntityAddressCityOrTown">Montclair</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20250902__20250902_zbYFkJu1Vkzd"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000017" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20250902__20250902_zat4pPmp78z1"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000018" name="dei:EntityAddressPostalZipCode">07042</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90E_edei--CityAreaCode_c20250902__20250902_zxARWvtgGDUg"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000019" name="dei:CityAreaCode">413</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20250902__20250902_ziI2oPL4pfZ3"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000020" name="dei:LocalPhoneNumber">398-2845</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--WrittenCommunications_c20250902__20250902_zhAKSYxqXIpd"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--SolicitingMaterial_c20250902__20250902_zsqkFqoFKfCh"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20250902__20250902_zpILKwmBV88d"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20250902__20250902_zEtUPw3zBoa2"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Title of each class</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Trading Symbol(s)</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_90A_edei--Security12bTitle_c20250902__20250902_zWCC5TzMS242"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_edei--TradingSymbol_c20250902__20250902_zWixJs8MnrI9"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000026" name="dei:TradingSymbol">TBH</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">The <span id="xdx_90A_edei--SecurityExchangeName_c20250902__20250902_zgpwRS3eySg3"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20250902__20250902_z1x3bAYWOjJd"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityExTransitionPeriod_c20250902__20250902_zFogfsVbWd7c"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 2, 2025, Brag House Holdings, Inc.
(the &#8220;<b>Company</b>&#8221;) entered into a securities purchase agreement (the &#8220;<b>Cash Purchase Agreement</b>&#8221;) with
CleanCore Solutions, Inc. (&#8220;<b>CleanCore</b>&#8221;) pursuant to which the Company purchased pre-funded warrants to purchase 4,000,000
shares of CleanCore&#8217;s class B common stock (the &#8220;<b>Cash Pre-Funded Warrants</b>&#8221;) for a purchase price of $1.00 in
cash per Cash Pre-Funded Warrant for a total purchase price of $4,000,000 in cash. The Company participated in CleanCore&#8217;s private
offering of pre-funded warrants (the &#8220;<b>Offering</b>&#8221;) issued in exchange for consideration of cash, Dogecoin, Bitcoin, Ethereum,
USDC, or USDT. The Offering closed on September 5, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cash Pre-Funded Warrants have a nominal exercise
price of $0.0001 (subject to standard adjustments for stock splits, stock dividends, recapitalizations, mergers and similar transactions),
include a cashless exercise provision, and may be exercised at any time commencing on the date that CleanCore files an amendment to its
articles of incorporation to increase the number of authorized shares of CleanCore&#8217;s class B common stock to a level sufficient
to permit the issuance of all securities contemplated pursuant to the Offering&#8217;s transaction documents until all of the Cash Pre-Funded
Warrants are exercised in full, subject to the Exchange Cap (as defined below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until CleanCore receives stockholder approval
for the issuance of all shares underlying all of the warrants issued pursuant to the Offering&#8217;s transaction documents, the aggregate
number of shares of CleanCore&#8217;s class B common stock that may be issued upon exercise of such warrants may not exceed 19.99% of
the number of shares of class B common stock issued and outstanding immediately prior to the signing of the Offering&#8217;s transaction
documents, or 2,773,858 shares (the &#8220;<b>Exchange Cap</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cash Purchase Agreement and Cash Pre-Funded
Warrant includes customary representations, warranties and covenants. They also provide that CleanCore will indemnify the Company, its
affiliates and/or its respective directors, officers, shareholders, members, partners, employees and agents against certain liabilities
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Cash Purchase Agreement, CleanCore
agreed that at any time during the period commencing from the six (6) month anniversary of the date of the Cash Purchase Agreement and
ending at such time that all of the securities issued to the Company may be sold without the requirement for CleanCore to be in compliance
with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if CleanCore (i) shall fail for any reason to
satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or
becomes such an issuer in the future, and CleanCore shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;<b>Public
Information Failure</b>&#8221;) then, in addition to the Company&#8217;s other available remedies, CleanCore shall pay to the Company,
in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell its securities,
an amount in cash equal to $1,000 per day of a Public Information Failure until the earlier of (a) the date such Public Information Failure
is cured and (b) such time that such public information is no longer required for that Purchaser to transfer its securities pursuant to
Rule 144. In the event CleanCore fails to make such payments in a timely manner, other than during the pendency of any bona fide dispute
over whether an alleged Public Information Failure has occurred, such payments shall bear interest at the rate of 1.5% per month (prorated
for partial months) until paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Cash Purchase Agreement and the Cash Pre-Funded Warrants does not purport to be complete and is qualified in its entirety by reference
to the full text of those documents attached as, respectively, Exhibits 10.1 and 4.1 hereto, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Registration Rights Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the entrance into the Cash
Purchase Agreement, the Company and CleanCore also entered into a registration rights agreement (the &#8220;<b>Registration Rights Agreement</b>&#8221;),
pursuant to which CleanCore agreed to file a registration statement on Form S-3 (the &#8220;<b>Registration Statement</b>&#8221;) with
the U.S. Securities and Exchange Commission (the &#8220;<b>SEC</b>&#8221;) within twenty (20) calendar days of the closing of the Offering
(the &#8220;<b>Filing Date</b>&#8221;) in order to register all shares of class B common stock issuable upon exercise of the Cash Pre-Funded
Warrants and any securities issued or then issuable upon any share split, dividend or other distribution, recapitalization or similar
event with respect to the foregoing (the &#8220;<b>Registrable Securities</b>&#8221;), and use its best efforts to cause the Registration
Statement to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later
than thirty (30) calendar days following the Filing Date or, in the event of a full review by SEC, ninety (90) calendar days following
the Filing Date (the &#8220;<b>Effectiveness Date</b>&#8221;). If: (i) the Registration Statement is not filed on or prior to the Filing
Date, (ii) CleanCore fails to file with the SEC a request for acceleration of the Registration Statement in accordance with Rule 461 promulgated
by the SEC pursuant to the Securities Act within five (5) trading days of the date that CleanCore is notified by the SEC that the Registration
Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, (iii) prior to the effective date of the Registration
Statement, CleanCore fails to file a pre-effective amendment and otherwise respond in writing to comments made by the SEC in respect of
the Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the SEC that such amendment is
required in order for the Registration Statement to be declared effective, (iv) the Registration Statement registering for resale all
of the Registrable Securities, subject to the cutback limitations set forth in the Registration Rights Agreement, is not declared effective
by the SEC by the Effectiveness Date, or (v) after the effective date of the Registration Statement, the Registration Statement ceases
for any reason to remain continuously effective as to all Registrable Securities included in the Registration Statement, or the Purchasers
are otherwise not permitted to utilize the prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive
calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any twelve
(12) month period (any such failure or breach being referred to as an &#8220;<span style="text-decoration: underline">Event</span>&#8221;, and for the purposes of clauses (i)
and (iv) above, the date on which such Event occurs, and for the purpose of clause (ii) above, the date on which such five (5) trading
day period is exceeded, and for the purpose of clause (iii) above, the date which such ten (10) calendar day period is exceeded, and for
the purpose of clause (v) above, the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being
referred to as &#8220;<span style="text-decoration: underline">Event Date</span>&#8221;), then, in addition to any other rights the Purchasers may have under the Registration
Rights Agreement or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable
Event shall not have been cured by such date) until the applicable Event is cured, CleanCore shall pay to the Company an amount in cash,
as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure. If CleanCore fails to pay any partial liquidated
damages in full within seven (7) days after the date payable, CleanCore will pay interest thereon at a rate of 18% per annum (or such
lesser maximum amount that is permitted to be paid by applicable law) to the Purchaser, accruing daily from the date such partial liquidated
damages are due until such amounts, plus all such interest thereon, are paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registration Rights Agreement includes customary
covenants and provides that CleanCore will indemnify the Company, its affiliates and/or its respective directors, officers, shareholders,
members, partners, employees and agents against certain liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of
the form of the Registration Rights Agreement attached as Exhibit 10.2 hereto, which is incorporated herein by reference.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; width: 9%"><b>Exhibit No.</b></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify; width: 90%"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>4.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025642801ex4-1_brag.htm">Pre-Funded Warrant issued on September 5, 2025</a></td></tr>
  <tr>
    <td>10.1</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="ea025642801ex10-1_brag.htm">Securities Purchase Agreement (Cash), dated September 1, 2025</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>10.2</td>
    <td>&#160;</td>
    <td><a href="ea025642801ex10-2_brag.htm">Registration Rights Agreement, dated September 1, 2025</a></td></tr>
  <tr>
    <td>104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>Date: September 8, 2025</td>
    <td colspan="2"><b>BRAG HOUSE HOLDINGS, INC. </b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>By: </td>
    <td style="border-bottom: black 1.5pt solid"><i>/s/ Lavell Juan Malloy, II</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name: </td>
    <td>Lavell Juan Malloy, II</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title: </td>
    <td>Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVsKwkAMRVfQPYT5lr6gYvtpURGrSCni72ijDLaTkhlfS3KXTlvEEAjJvSdXiIlY0VI1yHCclwVU2HaNtAglXpBRn9E58vUmAzdLvCpjWWo7rD8wJ8egY6Z+dHL3wflQBusMwjQIZ0GcQBRnSQr7rfB6PSd9UTVqq2QDUtewZ+pYoZX8Hj9U8kWa2veQdEA2inQGkR+O8gfiMIphRw/5JL4ZKIpceJOhPLFiunfOtXhZ1D0JiwZbF2dG+t/eF9PFSmo= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea025642801ex4-1_brag.htm
<DESCRIPTION>PRE-FUNDED WARRANT ISSUED ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt; width: 50%">Warrant Shares: 4,000,000</TD>
    <TD STYLE="font-size: 10pt; text-align: right; width: 50%">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Brag House Holdings, Inc. or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full
(the &ldquo;<U>Termination Date</U>&rdquo;), to subscribe for and purchase from CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 4,000,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of class B common stock of the Company,
par value 0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant (i) will occur automatically upon the later
to occur of (x) the date of effectiveness of the Stockholder Approval (as defined in the Purchase Agreement) and (y) the date of effectiveness
of the Authorization Amendment (the &ldquo;<U>Automatic Exercise Date</U>&rdquo;), with such automatic exercise to be effected based on
exercise amounts previously funded to the Company, or, in the event such amounts have not been funded, on a cashless basis, subject to
the limitations set forth in Section 2(e), without the requirement to deliver a Notice of Exercise (as defined below), and the Automatic
Exercise Date shall be deemed to be the date on which the Holder delivered to the Company a Notice of Exercise with respect to such automatic
exercise, and (ii)] may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company of a duly executed facsimile copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment)
of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date the Holder delivers the Notice of Exercise, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and this Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes hereof, a &ldquo;Trading
Day&rdquo; is a day on which the Common Stock is traded on a Trading Market (and if the Common Stock is not then listed or quoted on a
Trading Market, Trading Day means a Business Day).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Exercise Price</U>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the
Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder
shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Cashless Exercise</U>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.35in">(A) = </TD>
    <TD STYLE="font-size: 10pt; text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.35in">(B) =</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.35in">(X) = </TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of this Warrant being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Pre-Funded Warrants then outstanding and reasonably acceptable to the Company, the
reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Pre-Funded Warrants then outstanding and reasonably acceptable
to the Company, the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of this Warrant), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after
the delivery to the Company of the Notice of Exercise, and (ii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to use commercially reasonable
efforts to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date. Any portion
of this Warrant that has not previously been exercised as of the Automatic Exercise Date shall be automatically exercised as of such Automatic
Exercise Date pursuant to a cashless exercise, subject to the limitations set forth in Section 2(e).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of this Warrant and equivalent number of Warrant Shares for which such exercise was not honored and return any amount received
by the Company in respect of the Exercise Price for those Warrant Shares (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of this Warrant with an aggregate sale price giving rise to such purchase obligation of $10,000, under
clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the
Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding (the &ldquo;<U>Reported Outstanding Share Number</U>&rdquo;). Upon the written or oral
request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the
Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.
If the Company receives a Notice of Exercise from the Holder at a time when the actual number of outstanding shares of Common Stock is
less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares of Common Stock
then outstanding and, to the extent that such Notice of Exercise would otherwise cause the beneficial ownership of Holder together with
the Attribution Parties, as determined pursuant to this Section 2(e), to exceed the Beneficial Ownership Limitation, the Holder shall
then notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Notice of Exercise (such notice, the &ldquo;<U>Reduction
Notice</U>&rdquo;). Such issuance shall not be deemed to have occurred until the Holder provides the Reduction Notice (or a notice that
no reduction is needed) to the Company. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results
in the Holder, together with the Attribution Parties, collectively being deemed to beneficially own, in the aggregate, more than the Beneficial
Ownership Limitation, the number of shares so issued by which the aggregate beneficial ownership of the Holder and its Attribution Parties
exceeds such limitation (the &ldquo;<U>Excess Shares</U>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the
Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable
after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid
by the Holder for the Excess Shares and the Holder shall return the Excess Shares to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the total number of Shares and shares of
Common Stock underlying this Warrant issued to such Holder pursuant to the Purchase Agreement on the Closing Date and the denominator
of which is the aggregate number of Shares and shares of Common Stock underlying all Pre-Funded Warrants issued to all Purchasers pursuant
to the Purchase Agreement (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell or otherwise transfer
any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation Amount. In the
event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate, is less than
the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares
of Common Stock actually issued to such Holder shall be allocated to the remaining holders of Pre-Funded Warrants on a pro rata basis
in proportion to the shares of Common Stock underlying the Pre-Funded Warrants then held by each such holder. For the avoidance of doubt,
the restrictions of this Section 2(f) would no longer apply upon the receipt of the Stockholder Approval and the effectiveness of the
Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Restrictive Legends</U>.
If all or any portion of a Warrant is exercised at a time (i) while a registration statement covering the resale of the Warrant Shares
is effective under the Securities Act, (ii) following any sale of such Warrant Shares pursuant to Rule 144 (assuming cashless exercise
of this Warrant) and the Company is then in compliance with the current public information required under Rule 144, (iii) if such Warrant
Shares are eligible for sale under Rule 144 (assuming cashless exercise of this Warrant) without volume or manner-of-sale restrictions,
(iv) if at any time on or after the date hereof the Holder certifies that it is not an &ldquo;affiliate&rdquo; of the Company (as such
term is used under Rule 144) and that the Holder&rsquo;s holding period for purposes of Rule 144 is at least six (6) months, or (v) if
such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), the Warrant Shares issued upon such exercise shall be issued free of all legends. If at any time
following the date hereof a registration statement registering the resale of the Warrant Shares is not effective or is not otherwise available
for the resale of the Warrant Shares, the Company shall promptly notify the holders of the Pre-Funded Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and
available for the resale of the Warrant Shares (it being understood and agreed that the foregoing shall not impair the ability of the
Company to comply with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on
the date fixed therefor, the number of shares issuable upon exercise of this Warrant shall be recomputed accordingly as of the close of
business on such record date and thereafter the number of shares issuable upon exercise of this Warrant shall be adjusted pursuant to
this paragraph as of the time of actual payment of such dividends, and shall become effective immediately after the effective date in
the case of a subdivision, combination or re-classification.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents
or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
(the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;); provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement)
shall be considered a Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of Warrant Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to
any limitation in Section 2(e) on the exercise of this Warrant) (the &ldquo;<U>Fundamental Transaction Rights</U>&rdquo;). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company
herein; provided, however, that to the extent that the Holder&rsquo;s right to participate in any such Fundamental Transaction Rights
would result in the Holder and its Attribution Parties, collectively, beneficially owning in excess of the Beneficial Ownership Limitation
of the Common Stock that would be issued and outstanding following receipt of such Fundamental Transaction Rights (such excess amount
of Common Stock, the &ldquo;<U>Excess Fundamental Transaction Rights</U>&rdquo;), then the Holder shall not be entitled to participate
in such Fundamental Transaction Rights to the extent of the Excess Fundamental Transaction Rights (and shall not have the right to acquire
such Excess Fundamental Transaction Rights). The Excess Fundamental Transaction Rights shall be held in abeyance for the benefit of the
Holder until such time or times as (1) its right to receive some or all of the Excess Fundamental Transaction Rights would not result
in the Holder and its Attribution Parties beneficially owning Common Stock in excess of the Beneficial Ownership Limitation and (2) the
Holder so certifies in writing to the Company and specifies the number of shares of Common Stock it is able to receive without exceeding
the Beneficial Ownership Limitation, at which time or times the Holder shall be granted that portion of the Excess Fundamental Transaction
Rights (and any Excess Fundamental Transaction Rights granted, issued or sold on such initial Fundamental Transaction Rights or on any
subsequent Fundamental Transaction Rights to be held similarly in abeyance) to the same extent as if there had been no such limitation.
For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of whether
the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Redemption Right</U>.
In the event that the Authorization Amendment is not effective within ninety (90) days from the date hereof, the Holder shall have the
right, exercisable for a period of fifteen (15) business days following such date to require the Company to (i) redeem this Warrant at
a per Pre-Funded Warrant redemption price equal to the Per Share Purchase Price minus the exercise price of the Pre-Funded Warrants and
(ii) pay the amount of any unpaid liquidated damages owed (if any) to the Holder, payable in the case of each of foregoing clause (i)
or (ii), in cash in the same proportion and form as the Holder shall have paid the Per Share Purchase Price.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4.1 of the Purchase Agreement, this
Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon
surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified
in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading Days of
the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for this Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of this Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Authorized Shares</U>.
On or prior to the date hereof, the Company has obtained the written consent of the holders of a majority of its outstanding Common Stock
regarding the Authorization Amendment and has filed the definitive Schedule 14C information statement providing notice of the Authorization
Amendment and will use its best efforts to respond to any comments received from the Commission as soon as practicable. The Company shall
file the Authorization Amendment with the Secretary of State of Nevada no later than the 21<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>
day after the mailing of the Schedule 14C information statement. From and after the date of the filing of the Authorization Amendment,
the Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the
duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such
reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable
law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that
all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the
purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue). If the Authorization Amendment is not effective within
30 days following the Issue Date of this Warrant (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and the
date on which such Event occurs, being referred to as the <U>&ldquo;Event Date</U>&rdquo;), then, in addition to any other rights the
Holder may have hereunder or under applicable law, on the Event Date and on each monthly anniversary of each such Event Date (if the applicable
Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to the Holder an amount in cash,
as partial liquidated damages and not as a penalty, equal to $1,000 per day for such failure. If the Company fails to pay any partial
liquidated damages pursuant to this Section in full within seven (7) days after the date payable, the Company will pay interest thereon
at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily
from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial
liquidated damages pursuant to the terms hereof shall apply on daily pro rata basis for any portion of a month prior the cure of an Event.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) <U>No Expense Reimbursement</U>.
The Holder shall in no way be required to pay, or to reimburse the Company for, any fees or expenses of the Transfer Agent in connection
with the issuance or holding or sale of Common Stock, this Warrant and/or Warrant Shares. The Company shall solely be responsible for
any and all such fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; width: 35%"><I>/s/ Clayton Adams</I></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Name: </TD>
    <TD STYLE="text-align: justify">Clayton Adams</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 1pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ea025642801ex10-1_brag.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT (CASH), DATED SEPTEMBER 1, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of September 1, 2025, between CleanCore Solutions, Inc., a corporation organized under
the laws of State of Nevada (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b)
of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to sell to the Purchasers, and each of the Purchasers desire to purchase from the Company in the offering contemplated by this Agreement
(the &ldquo;<U>Offering</U>&rdquo;), severally and not jointly, upon the terms and subject to the conditions stated in this Agreement,
Pre-Funded Warrants (as defined below) to purchase Shares (as defined below) substantially in the form attached hereto as <U>Exhibit A</U>.
The Securities (as defined below) consist of the Pre-Funded Warrants and the Pre-Funded Warrant Shares (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the Securities, the parties hereto will execute and deliver the Registration Rights Agreement, substantially in the form
attached hereto as <U>Exhibit B</U>, pursuant to which the Company will agree to provide certain registration rights in respect of the
Pre-Funded Warrant Shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the sale of the Securities
sold in the Offering will be on a &ldquo;commercially reasonable best efforts&rdquo; basis and there will be no minimum or maxim offering
amount and no assurance can be given that all or any portion of the Securities offered hereby will be sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, HoD (as defined below)
shall invest $10,000,000 in the Offering through the contribution of a combination of cash and Dogecoin (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Management
Fees</U>&rdquo; shall have the meaning ascribed to such term in Section 5.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorization Amendment</U>&rdquo;
means an amendment to the Company&rsquo;s Articles of <FONT STYLE="font-size: 10pt"><SUP>1 </SUP></FONT>Incorporation, duly adopted and
filed with the Nevada Secretary of State, that increases the number of authorized shares of Common Stock to a level sufficient to permit
the issuance of all Pre-Funded Warrant Shares, the Strategic Advisor Warrant Shares and the shares issuable to the Placement Agent upon
the exercise of warrants issuable to the Placement Agent at Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Pre-Funded Warrants, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the class B common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Bevilacqua PLLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>&ldquo;Company Nevada Counsel</U>&rdquo;
means Fennemore Craig, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Dogecoin</U>&rdquo;
means the native token of the Dogecoin blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Registration Statement registering for resale all Pre-Funded Warrant Shares has been
declared effective by the Commission, (b) all of the Pre-Funded Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant
to Rule 144 without the requirement for the Company to be in compliance with the current public information requirement of Rule 144 and
without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing, or (d) all of the Pre-Funded Warrant
Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale
restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">We will be issuing PFWs only in the offering which will be subject to shareholder approval. The majority shareholder&rsquo;s written consent was obtained and a Schedule 14C filed for the approval of the offering. We also have written consent and a 14C filed for an increased in the authorized shares.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow Agent</U>&rdquo;
means Continental Stock Transfer &amp; Trust Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Cap</U>&rdquo;
means the Company&rsquo;s principal Trading Market&rsquo;s limitation against a Purchaser&rsquo;s acquisition of shares of Common Stock
pursuant to the Transaction Documents, to the extent that after giving effect thereto, the aggregate number of shares of Common Stock
that would be issued pursuant to the Transaction Documents and the transactions contemplated thereby would exceed 19.99% of the number
of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement, which number of shares would be
reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series
of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance (a) of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or
option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) of shares
of Common Stock upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options, rights
or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities; (c) of shares of Common Stock upon conversion or settlement of outstanding debt as of the date
hereof in an amount not to exceed $100,000; (d) of the Strategic Advisor Warrants, the Placement Agent Warrants, the Strategic Advisor
Warrant Shares and the Placement Agent Warrant Shares; (e) of shares of Common Stock or pre-funded warrants in a private placement or
other transaction with fundamental or technical institutional investors at a price per share or pre-funded warrant greater than the Per
PFW Purchase Price; (f) of securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person)
which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a business synergistic with the business
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities; and (g) of any shares of Common Stock issued pursuant to an at-the-market sales agreement entered into by the Company,
the Placement Agent and any sales agents designated by the Placement Agent provided that, prior to the 30 day anniversary of the Effective
Date, any such sales are at a price per share greater than the Per PFW Purchase Price; (h) of securities to banks, equipment lessors or
other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction
approved by a majority of the disinterested directors of the Company, (i) of securities issued to in connection with the provision of
goods pursuant to transactions approved by a majority of the disinterested directors of the Company and (j) of securities issued in connection
with sponsored research, collaboration, technology license, development, marketing or other similar agreements or strategic partnerships
approved a majority of the disinterested directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD</U>&rdquo; means
House of Doge Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD Contribution</U>&rdquo;
means a combination, valued at $10,000,000 in the aggregate, of (i) cash and (ii) Dogecoin. The Dogecoin comprising the HOD Contribution
shall equal (a) the portion of the contribution paid in Dogecoin, divided by (b) the spot exchange rate for Dogecoin as published by Coinbase.com
at 12:00 p.m. (New York City time) on the date of the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legacy Business</U>&rdquo;
means the business of the Company on the date hereof and immediately prior to the Closing and specifically excludes any digital asset
treasury business that the Company may engage in whether before or after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreements</U>&rdquo;
means the Lock-Up Agreements, dated as of the date hereof, by and among the Company and the directors and executive officers, in the form
of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option Agreement</U>&rdquo;
means that certain agreement in the form of <U>Exhibit D</U> hereto, by and between the Company and Clayton Adams, in his individual capacity,
pursuant to which Mr. Adams shall be granted an option (the &ldquo;<U>Option</U>&rdquo;), exercisable by Mr. Adams at any time following
the date that is one hundred eighty (180) days after the Closing Date, to elect, in his sole discretion, to either: (i) cause the Company
to effect a spin-off of the Legacy Business to all shareholders of the Company through a dividend of all equity interests of such business,
or (ii) permit Mr. Adams or one or more persons designated by him to acquire the Legacy Business a purchase price that is mutually agreeable
to the Company (as approved by a majority of the independent directors of the Company) and Mr. Adams, provided that such purchase price
is supported by an independent fairness opinion rendered by a Newbridge Securities Corporation or another nationally recognized investment
bank mutually selected by Mr. Adams and the independent directors of the Company, all on terms and conditions set forth in the Option
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per PFW Purchase
Price</U>&rdquo; equals $1.00, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agency
Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent in respect of the
placement of the Securities, dated September 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means, collectively, Maxim Group LLC and Curvature Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrants</U>&rdquo; means the warrants to purchase Common Stock issuable to the Placement Agent under the Placement Agency Agreement,
which Placement Agent Warrants shall not be exercisable until the filing of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon the exercise of the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the Pre-Funded Common Stock purchase warrants in the form of <U>Exhibit A</U> delivered to the Purchasers at the
Closing in accordance with Section&#8239;2.2(a)&#8239;hereof, which Pre-Funded Warrants shall be subject to the Exchange Cap and not be
exercisable until the filing of the Authorization Amendment and shall expire when exercised in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means a resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the Purchasers
of the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Agreement</U>&rdquo; means that certain Strategic Advisor Agreement between HoD and the Company to be executed on or prior to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means 8,750,021 warrants to purchase Common Stock having an exercise price of $1.00 and 5,250,013 warrants to purchase
Common Stock having an exercise price of $1.33 to be issued to HoD (or an affiliate thereof) in connection with the entry into the Strategic
Advisor Agreement, which Strategic Advisor Warrants shall not be exercisable until the filing of the Authorization Amendment.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Pre-Funded Warrants purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts
shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreements, the Registration Rights Agreement, the Pre-Funded Warrants, the Treasury Management Agreement,
the Strategic Advisor Agreement and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Securities Transfer Corporation, with a mailing address of 2901 N Dallas Parkway, Suite 380, Plano, TX 75093, and any successor
transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Management
Agreement</U>&rdquo; means that certain Asset Management Agreement among the Company and the Treasury Manager, to be executed on or prior
to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and the Common Stock is listed or quoted for trading on the OTCQB or OTCQX, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other
cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
the number of Pre-Funded Warrants, for the aggregate purchase price, set forth on the Purchaser&rsquo;s signature page. Each Purchaser
shall deliver to the Escrow Agent, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount
as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Securities,
as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices
of the Placement Agent or such other location as the parties shall mutually agree, including taking place remotely by electronic transfer
of the Closing documentation. In the event that the Closing has not occurred within five (5) Business Days after the expected Closing
Date, unless otherwise agreed by the Company and a Purchaser solely in relation to such Purchaser&rsquo;s subscription hereunder, the
Company shall, promptly (but no later than one Business Day thereafter) return the previously wired Subscription Amount by wire transfer
of United States dollars in immediately available funds to the account specified by each applicable Purchaser; provided that, unless this
Agreement has been terminated pursuant to Section 5.1, such return of funds shall not terminate this Agreement or relieve such Purchaser
of its obligation to purchase, or the Company of its obligation to issue and sell, the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the legal opinions of
Company Counsel and Company Nevada Counsel, each dated as of the Closing Date, in forms reasonably acceptable and addressed to the Placement
Agent and the Purchasers and executed by such counsels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) a copy of the irrevocable
instructions to the Transfer Agent, in form and substance reasonably satisfactory to the Purchasers, instructing the Transfer Agent to
deliver from time to time, upon exercise of the Pre-Funded Warrants, the Pre-Funded Warrant Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) a Pre-Funded Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s
Subscription Amount divided by the Per PFW Purchase Price, with an exercise price equal to $0.0001, which shall have been pre-funded at
the Closing, subject to adjustment as provided therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) the Strategic Advisor
Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vi) the Placement Agent Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vii) the wire instructions
of the Escrow Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(viii) the Lock-Up Agreements
duly executed by the Company and the directors and executive officers signatory thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ix) the Registration Rights
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) the Treasury Management
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xi) the Strategic Advisor
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xii) a certificate of the
Secretary of the Company (the &ldquo;<U>Secretary&rsquo;s Certificate</U>&rdquo;), dated as of the Closing Date, (a) certifying the resolutions
adopted by the Board of Directors approving the transactions contemplated by this Agreement and the other Transaction Documents and the
issuance of the Pre-Funded Warrants (as applicable), (b) certifying the current versions of the Articles of the Incorporation of the Company
and Bylaws and (c) certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on
behalf of the Company, in the form attached hereto as <U>Exhibit E</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiii) a certificate dated
as of the Closing Date and signed by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying
to the fulfillment of the conditions specified in Sections 2.3(a)(i) and 2.3(a)(ii), in the form attached as <U>Exhibit F</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiv) a certificate evidencing
the formation and good standing of the Company issued by the Secretary of State of Nevada, as of a date within five (5) Business Days
of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xv) a certified copy of the
Articles of Incorporation, as certified by the Secretary of State (or comparable office) of Nevada, as of a date within five (5) Business
Days of the Closing Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xvi) executed written consents
of Company stockholders holding the requisite number of the Company&rsquo;s voting shares that are needed to approve the following: (i)
the approval of the Authorization Amendment; (ii) the approval of the transactions as contemplated by the Transaction Documents; (iii)
the approval of the transactions as an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company
Guide for purposes of compliance with NYSE American rules; and (iv) such other approvals as are necessary or desirable in connection with
the transaction (approval of all such proposals, the &ldquo;<U>Stockholder Approval</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xvii) evidence that the Pre-Funded Warrant Shares
(as applicable) to be issued to the Purchasers have been approved for listing on the Principal Market, subject only to official notice
of issuance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xviii) evidence that all the outstanding class
A common stock of the Company has been converted to class B common stock; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xix) such other instruments,
certificates, documents or materials as may be reasonably requested by Purchaser in connection with the consummation of the transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the Registration Rights
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) to the Escrow Agent,
such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The obligations of the
Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by each
Purchaser of the items set forth in Section 2.2(b) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">(iv) the execution by the Company and Clayton
Adams, in his individual capacity, of the Option Agreement;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(v) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(vi) The Company shall
have obtained in a timely fashion any and all consents, Material Permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(vii) HoD or its wholly-owned
subsidiary Dogecoin Ventures, Inc. shall have delivered the HoD Contribution as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The respective obligations
of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all respects
when made of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they
shall be accurate as of such date) and the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by the
Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) there shall have been
no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) from the date hereof to
the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or any
Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(vi) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(vii) the Company
shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify; text-indent: 34.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4 <U>Exchange Cap; Authorization
Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company shall not
be obligated to issue any Pre-Funded Warrant Shares, Strategic Advisor Warrant Shares or Placement Agent Warrant Shares (collectively,
&ldquo;<U>Exchange-Cap Securities</U>&rdquo;) to the Purchasers, HoD or the Placement Agent, as applicable, pursuant to any of the Transaction
Documents if the issuance, when aggregated with all prior issuances of Shares and Exchange-Cap Securities to such Persons, would exceed
the Exchange Cap, except that such limitation shall not apply in the event that (A) the Stockholder Approval contemplated by Section 2.2(a)(xvi)
becomes effective in accordance with its terms, or (B) the Company obtains a written opinion from outside counsel to the Company that
such approval is not required, which opinion shall be reasonably satisfactory to HoD and the holders of a majority in interest of the
Securities still held by the Purchasers. Until such approval is obtained (or the delivery of such opinion), (A) HoD shall not be able
to exercise the Strategic Advisor Warrant, (B) the Placement Agent shall not be able to exercise the Placement Agent Warrant, and (C)
no Purchaser shall be issued Pre-Funded Warrant Shares, upon exercise of any of its rights under the Pre-Funded Warrants, in an amount
greater than the product of the Exchange Cap multiplied by a fraction, the numerator of which is the total number of Shares and shares
of Common Stock underlying the Securities issued to such Purchaser pursuant to this Agreement on the Closing Date and the denominator
of which is the aggregate number of Shares and shares of Common Stock underlying all the Securities issued to all the Purchasers pursuant
to this Agreement (with respect to each Purchaser, the &ldquo;<U>Exchange Cap Allocation</U>&rdquo;). In the event that any holder of
Securities shall exercise all of such holder&rsquo;s rights under the Transaction Documents into a number of shares of Common Stock which,
in the aggregate, is less than such holder&rsquo;s Exchange Cap Allocation, then the difference between such holder&rsquo;s Exchange Cap
Allocation and the number of shares of Common Stock actually issued to such holder shall be allocated to the respective Exchange Cap Allocations
of the remaining holders of Securities on a pro rata basis in proportion to the shares of Common Stock underlying the Securities then
held by each such holder. The Pre-Funded Warrants, the Strategic Investor Warrants and the Placement Agent Warrants shall contain prohibitions
on the exercise of such warrants that are consistent with this Section 2.4(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Pre-Funded Warrants,
the Strategic Investor Warrants and the Placement Agent Warrants shall also prohibit the exercise of such warrants until the Authorization
Amendment becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of
the Disclosure Schedules, the Company hereby makes the following representations and warranties as of the date hereof and as of the Closing
Date (unless as of a specific date therein, in which case as of such date) to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers
by the Company. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and
clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document or the Treasury Management Agreement,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document or the Treasury Management Agreement (any of (i), (ii) or (iii),
a &ldquo;<U>Material Adverse Effect</U>&rdquo;), and no Proceeding has been instituted in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement and each of the other Transaction Documents or the Treasury Management Agreement by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company,
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or
therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party
or the Treasury Management Agreement has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party or the
Treasury Management Agreement, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section
4.4 of this Agreement, (ii) the notice and/or additional listing application(s) to each applicable Trading Market for the listing of the
Pre-Funded Warrant Shares for trading thereon in the time and manner required thereby; (iii) the registration statement required to be
filed by the Registration Rights Agreement, (iv) the filing of Form D with the Commission and such filings as are required to be made
under applicable state securities laws, and (v) filing the Second Definitive Information Statement (as defined below) with the Commission
in connection with the August 22 Written Consent (as defined below) (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;). For greater
certainty, the Company is not required to submit an original listing application to the Company&rsquo;s principal Trading Market in connection
with the offer and sale of the Securities and effecting the Doge treasury strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Issuance of the Securities</U>.
The Pre-Funded Warrants are duly and validly authorized and, when issued and paid for in accordance with this Agreement, will be duly
and validly issued and constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction
Documents. The Pre-Funded Warrant Shares, when issued in accordance with the terms of the Pre-Funded Warrants, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the
Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Pre-Funded Warrants. Subject to the accuracy of the representations and warranties made by the Purchasers
in Section 3.2, the offer and sale of the Securities to the Purchaser is and will be in compliance with applicable exemptions from (i)
the registration and prospectus delivery requirements of the Securities Act and (ii) the registration and qualification requirements of
applicable securities laws of the states of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in <U>Schedule 3.1(g)</U> or as a result of the purchase and sale of the
Securities (and the issuance of the Strategic Advisor Warrants and Placement Agent Warrants) there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any
Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or
&ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities
laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and
sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>SEC Reports; Financial
Statements</U>. Since April 25, 2024, except as set forth on <U>Schedule 3.1(h)</U>, the Company has filed all reports, schedules, forms,
statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none
of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
There are no material outstanding or unresolved comment letters from the staff of the Division of Corporate Finance of the Commission
with respect to any of the SEC Reports as of the date hereof. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. No other
financial statements or supporting schedules are required to be included pursuant to the Exchange Act. The other financial and statistical
information included in the SEC Reports present fairly the information included therein and have been prepared on a basis consistent with
that of the financial statements that are included in the SEC Reports and the books and records of the Company. There are no material
off-balance sheet transactions, arrangements or obligations (including contingent obligations) of the Company or other persons that would
reasonably be expected to result in a Material Adverse Effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except
as set forth in <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement and the entry into the Treasury Management Agreement, no event, liability,
fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>. Except
as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations, approvals, consents, registrations, licenses qualifications,
certifications and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their
respective businesses as such businesses are described in the SEC Reports, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any
Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of
any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Transactions with Affiliates
and Employees</U>. Except as set forth in <U>Schedule 3.1(r)</U>, none of the officers, directors or beneficial holders of 5% or more
of any class of capital shares of the Company, or officers or directors of the Company or any Subsidiary and, to the knowledge of the
Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from
or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under
any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company has not received any notice of correspondence from its independent registered public accounting firm, governmental entity or other
Person relating to any potential material weakness in any part of the internal controls over financial reporting of the Company. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Certain Fees</U>. Except
for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees
or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by the Transaction Documents. For the avoidance of doubt, the Purchasers acknowledge that
the Asset Manager will receive payment for services rendered under the Asset Management Agreement and will be reimbursed for the Asset
Management Fees in connection with providing services under the Asset Management Agreement and in each case, such payment for the Asset
Management Fees may be made to the Asset Manager directly out of the funds that the Asset Manager is managing which will include the proceeds
from this Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale
of the Securities hereunder does not contravene the rules and regulations of the Company&rsquo;s Trading Market.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Investment Company;
Commodity Status of Dogecoin</U>. The Company is not, and is not an Affiliate of, and immediately after giving effect to the receipt of
payment for the Securities and the application of the proceeds contemplated by Section 4.7, will not be, and will not be deemed to be,
nor will it be controlled by or be under common control with, an &ldquo;investment company&rdquo; within the meaning of, or otherwise
subject to registration or regulation under, the Investment Company Act of 1940, as amended (the &ldquo;<U>ICA</U>&rdquo;). In furtherance
of the foregoing, the Company represents and warrants that Dogecoin, which constitutes the principal asset that the Company expects to
acquire, hold, exchange, stake, transfer, lend, pledge, or otherwise use or dispose of with the proceeds of the offering, is properly
characterized as a &ldquo;commodity&rdquo; within the meaning of the Commodity Exchange Act of 1936, as amended (the &ldquo;<U>CEA</U>&rdquo;),
and the regulations, interpretations, and guidance of the Commodity Futures Trading Commission (&ldquo;<U>CFTC</U>&rdquo;) promulgated
thereunder, and is not, and will not be deemed to be, a &ldquo;security&rdquo; as that term is defined in Section 2(a)(1) of the Securities
Act of 1933, as amended, Section 3(a)(10) of the Securities Exchange Act of 1934, as amended, or any analogous provision of state &ldquo;blue
sky&rdquo; or other securities laws. The Company has a reasonable basis, after consultation with experienced counsel, for the conclusion
that Dogecoin constitute a commodity for all purposes of the federal commodities laws and are outside the scope of the federal securities
laws, and no governmental authority having jurisdiction over the Company, Dogecoin, or the transactions contemplated hereby has asserted
to the Company that Dogecoin should be treated as a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>Registration Rights</U>.
Except as disclosed in Schedule 3.1(w) and other than to each of the Purchasers pursuant to the Registration Rights Agreement, no Person
has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary. Other than pursuant to the Registration Rights Agreement, no Person has any right to cause the Company to effect the
registration under the Securities Act covering the transfer of any securities of the Company and there are no other stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) <U>NYSE American</U>.
The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading
on the NYSE American under the symbol &ldquo;ZONE&rdquo;. As of the date of this Agreement and the Closing Date, the Company is in compliance
with all listing and maintenance requirements of NYSE American applicable to the Company. As of the date of this Agreement and the Closing
Date, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company
by NYSE American or the Commission, respectively, to prohibit or terminate the listing of the Common Stock on the NYSE American or to
deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date of this Agreement and the Closing Date
that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The shares
of Common Stock are currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depositary Trust Company (or such other established clearing corporation) in
connection with such electronic transfer. The Company has taken no action as of the date of this Agreement that is designed to terminate,
or which to the knowledge of the Company is likely to have the effect of terminating, the registration of the Common Stock under the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s articles of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the offer and sale of the Securities, by the
Company to the Purchasers as contemplated hereby and the Purchasers&rsquo; ensuing ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Asset Management
Agreement and the representations made in Section 3.1(i), the Company confirms that neither it nor any other Person acting on its behalf
has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material,
non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules
to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior
or ensuing offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, (ii) eliminate the availability of the exemption from registration under Regulation D under the Securities Act
in connection with the offer and sale by the Company of the Securities or (iii) any applicable shareholder approval provisions of any
Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Indebtedness</U>.
<U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary,
or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable or accrued payroll liabilities
incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>. The
Company and its Subsidiaries each (i) has made or filed all material United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all material taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.
No audits, examinations, or other proceedings with respect to any material amounts of taxes of the Company and its subsidiaries are presently
in progress or have been asserted or proposed in writing without subsequently being paid, settled or withdrawn. There are no liens on
any of the assets of the Company. At all times since inception, the Company has been and continues to be classified as a corporation for
U.S. federal income tax purposes. Neither the Company nor any of its Subsidiaries has been a United States real property holding corporation
within the meaning of Code Section 897(c)-2 during the period specified in Code Section 897(c)(1)(A)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities as contemplated hereby by
any form of &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as such terms are defined in Regulation D under the
Securities Act). The Company and any Person acting on behalf of the Company has offered the Securities for sale as contemplated hereby
only to the Purchasers and certain other &ldquo;qualified purchasers&rdquo; within the meaning of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law or (iv) violated in any material respect any provision of FCPA.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i)
is an independent registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to
the financial statements to be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that, to its knowledge, each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that, to its knowledge, no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) <U>Acknowledgment Regarding
Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections
3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company
to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall
not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction.
The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Pre-Funded Warrant
Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of
the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Employee Benefits</U>.
Except as would not be reasonably likely to result in a Material Adverse Effect, each Benefit Plan has been established and administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code, the Patient Protection and Affordable
Care Act of 2010, as amended, and other applicable laws, rules and regulations. The Company and its Subsidiaries are in compliance with
all applicable federal, state and local laws, rules and regulations regarding employment, except for any failures to comply that are not
reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. There is no labor dispute, strike or work stoppage
against the Company or its Subsidiaries pending or, to the knowledge of the Company, threatened which may interfere with the business
activities of the Company, except where such dispute, strike or work stoppage is not reasonably likely, individually or in the aggregate,
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Off Balance Sheet
Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of the Subsidiaries and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in its Exchange Act filings and is not so disclosed
or that otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the terms of the
Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date
such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option
plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Anti-Bribery and Anti-Money
Laundering Laws</U>. Each of the Company, its subsidiaries and, to the knowledge of the Company, any of their respective officers, directors,
supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will
not violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but
not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials
in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended,
the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (B) anti-money laundering laws, including,
but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money
laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international
anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force
on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or
organization continues to concur, all as amended, and any executive order, directive, or regulation pursuant to the authority of any of
the foregoing, or any orders or licenses issued thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) of Regulation D under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered
Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy
of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>No Additional Agreements</U>.
There are no agreements or understandings between the Company and any Purchaser with respect to the transactions contemplated by the Transaction
Agreements other than (i) as specified in the Transaction Agreements and (ii) any side letter agreements with any of the Purchasers in
connection with such other Purchaser&rsquo;s agreement to purchase Securities thereunder on terms particular to compliance with any law,
regulation or policy specifically applicable to such other Purchaser or its affiliates or related funds or in connection with the taxable
status of such other Purchaser or its affiliates or related funds or other terms that are immaterial to such Purchaser, which side letters
the Company has shared with all Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Cybersecurity</U>.
To the knowledge of the Company, there has been no security breach or other compromise of or relating to any of the Company&rsquo;s or
any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data,
in each case, except as could not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; (ii) the
Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries
have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the
integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented
backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>Compliance with Data
Privacy Laws</U>. The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state,
federal and foreign data privacy and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer,
disposal, or any other processing (collectively &ldquo;<U>Process</U>&rdquo; or &ldquo;<U>Processing</U>&rdquo;) of Personal Data, including
without limitation HIPAA, the UK General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;), and all other local, state, federal,
national, supranational and foreign laws relating to the regulation of the Company or its subsidiaries, and the regulations promulgated
pursuant to such statutes and any state or non-U.S. counterpart thereof (collectively, the &ldquo;<U>Privacy Laws</U>&rdquo;). To ensure
material compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take all appropriate steps
necessary to ensure compliance in all material respects with their policies and procedures relating to data privacy and security, and
the Processing of Personal Data and Confidential Data (the &ldquo;<U>Privacy Statements</U>&rdquo;). The Company and its subsidiaries
have, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, at all times
since inception provided accurate notice of their Privacy Statements then in effect to its customers, employees, third party vendors and
representatives. None of such disclosures made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete,
or in material violation of any Privacy Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) <U>Transactions with
Affiliates and Employees</U>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the SEC Reports
that is not so described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) Prior Stockholder Consents;
<U>Information Statements</U>. On August 11, 2025, Company stockholders owning as of such date at least a majority of the outstanding
shares of class A common stock and class B common stock of the Company, voting together as a single class, duly executed a written consent
in lieu of a meeting, dated August 11, 2025 (the &ldquo;<U>August 11 Written Consent</U>&rdquo;), which authorized and approved an amendment
to the Company&rsquo;s Articles of Incorporation to increase the Company&rsquo;s authorized shares of class B common stock from 250,000,000
shares to 2,000,000,000 shares. On August 12, 2025, the Company filed a preliminary information statement on Schedule 14C with the Commission
with respect to the August 11 Written Consent (the &ldquo;<U>First Preliminary Information Statement</U>&rdquo;), on August 22, 2025,
the Company filed a definitive information statement on Schedule 14C with the Commission with respect to the August 11 Written Consent
(the &ldquo;<U>First Definitive Information Statement</U>&rdquo;), and, on August 22, 2025, the Company first mailed the First Definitive
Information Statement to its stockholders, in each case, in accordance with applicable law. On August 22, 2025, Company stockholders owning
as of such date at least a majority of the outstanding shares of class A common stock and class B common stock of the Company, voting
together as a single class, duly executed a written consent in lieu of a meeting, dated August 22, 2025 (the &ldquo;<U>August 22 Written
Consent</U>&rdquo; and, together with the August 11 Written Consent, the &ldquo;Written Consents&rdquo;), which approved the issuance
of up to $250 million of securities in one or more non-public offerings, on the terms and conditions described in the Second Preliminary
Information Statement (as defined below). On August 22, 2025, the Company filed a preliminary information statement on Schedule 14C with
the Commission with respect to the August 22 Written Consent (the &ldquo;<U>Second Preliminary Information Statement</U>&rdquo;) in accordance
with applicable law. The Written Consents were duly adopted in accordance with applicable law and the Company&rsquo;s Articles of Incorporation
and Bylaws, and no other stockholder consents or approvals are required from the Company&rsquo;s stockholders in order for the Company&rsquo;s
stockholders to approve the Authorization Amendment, the transactions contemplated by the Transaction Documents or the transactions as
an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company Guide for purposes of compliance with
NYSE American rules. Other than the completion of the procedures set forth herein and the approval for listing on the Principal Market
of the Pre-Funded Warrant Shares (as applicable) issued or to be issued to the Purchasers, subject only to official notice of issuance,
no further consent, approval, waiver, authorization, registration, license, qualification, certificate, notice or filing is required to
file and make effective the Authorization Amendment with the Secretary of State of Nevada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, severally and not jointly, hereby represents
and warrants as of the date hereof and as of the Closing Date (unless as of a specific date therein, in which case they shall be accurate
as of such date) to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(a) Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Understandings or Arrangements</U>.
Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such
Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal
and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; within the meaning
of, and have not been registered under, the Securities Act or any applicable state securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Investment Representations
and Warranties</U>. The Purchaser hereby represents and warrants that, as of the date of this Agreement and the Closing Date, it is, if
an entity, a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule 144A under the Securities Act) or an institutional &ldquo;accredited
investor&rdquo; as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act; or (ii) if an individual,
is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D of the Securities Act and has such knowledge
and experience in financial and business matters as to be able to protect its own interests in connection with an investment in the Securities.
The Purchaser further represents and warrants that (x) it is capable of evaluating the merits and risk of such investment, and (y) that
it has not been organized for the purpose of acquiring the Securities and is an &ldquo;institutional account&rdquo; as defined by FINRA
Rule 4512(c). The Purchaser understands and agrees that the offering and sale of the Securities has not been registered under the Securities
Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving
a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser&rsquo;s
representations as expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Intent</U>. The Purchaser
is purchasing the Securities, solely for the Purchaser&rsquo;s own account and not for the account of others, and not with a view to the
resale or distribution of any part thereof in violation of the Securities Act, and the Purchaser has no present intention of selling,
granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the
Purchaser&rsquo;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable
federal and state securities laws. Notwithstanding the foregoing, if the Purchaser is purchasing the Securities as a fiduciary or agent
for one or more investor accounts, the Purchaser has full investment discretion with respect to each such account, and the full power
and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. The Purchaser
has no present arrangement to sell the Securities to or through any person or entity. The Purchaser understands that the Securities must
be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from
registration is available. Nothing contained herein shall be deemed a representation or warranty by the Purchaser to hold the Securities
for any period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Investment Experience;
Ability to Protect Its Own Interests and Bear Economic Risks</U>. The Purchaser acknowledges that it can bear the economic risk and complete
loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business
matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby,
and the Purchaser has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Purchaser has
considered necessary to make an informed investment decision. The Purchaser acknowledges that the Purchaser (i) is a sophisticated investor,
experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in
general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent
judgment in evaluating its participation in the purchase of the Securities. The Purchaser acknowledges that the Purchaser is aware that
there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company&rsquo;s
filings with the Commission. Alone, or together with any professional advisor(s), the Purchaser has adequately analyzed and fully considered
the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Purchaser. The Purchaser
is, at this time and in the foreseeable future, able to afford the loss of the Purchaser&rsquo;s entire investment in the Securities and
the Purchaser acknowledges specifically that a possibility of total loss exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Independent Investment
Decision</U>. The Purchaser understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of
the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. The Purchaser
has consulted such professional advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase
of the Securities hereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Securities Not Registered;
Legends</U>. The Purchaser acknowledges and agrees that the Securities are being offered in a transaction not involving any public offering
within the meaning of the Securities Act, and the Purchaser understands that the Securities have not been registered under the Securities
Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and
that the Securities must continue to be held and may not be offered, resold, transferred, pledged or otherwise disposed of by the Purchaser
unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration and in each case in
accordance with any applicable securities laws of any state of the United States. The Purchaser understands that the exemptions from registration
afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various
conditions including, but not limited to, the time and manner of sale, the holding period and on requirements relating to the Company
which are outside of the Purchaser&rsquo;s control and which the Company may not be able to satisfy, and that, if applicable, Rule 144
may afford the basis for sales only in limited amounts. The Purchaser acknowledges and agrees that it has been advised to consult legal
counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Securities. The Purchaser acknowledges that no
federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings or determination
as to the fairness of this investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchaser understands
that any certificates or book entry notations evidencing the Securities may bear one or more legends in substantially the following form
and substance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&ldquo;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO AN EXEMPTION FROM REGISTRATION SUCH AS RULE 144 UNDER THE SECURITIES ACT, (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV) THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).&rdquo;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Securities
may contain a legend regarding affiliate status of the Purchaser, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>No General Solicitation</U>.
The Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company. Purchaser became aware
of this offering of the Securities solely by means of direct contact from the Placement Agent or directly from the Company as a result
of a pre-existing, substantive relationship with the Company or the Placement Agent, and/or their respective advisors (including, without
limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates,
directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to Purchaser
solely by direct contact between Purchaser and the Company, the Placement Agent and/or their respective representatives. Purchaser did
not become aware of this offering of the Securities, nor were the Securities offered to Purchaser, by any other means, and none of the
Company and/or its respective representatives (other than the Placement Agent acting as a broker-dealer) acted as investment advisor,
broker or dealer to Purchaser. The Purchaser is not purchasing the Securities as a result of any general or public solicitation or general
advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any
newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general
solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Risk Factors</U>. The
Purchaser understands and acknowledges that its purchase of the Securities is a speculative investment that involves a high degree of
risk and the potential loss of their entire investment and has carefully read and considered the matters and Risk factors set forth in
the SEC Reports and in <U>Exhibit G</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Certain Trading Activities</U>.
Other than consummating the transaction contemplated hereby, the Purchaser has not, nor has any Person acting on behalf of or pursuant
to any understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities
of the Company during the period commencing as of the time that the Purchaser was first contacted by the Company or any other Person acting
on the Company&rsquo;s behalf regarding the transaction contemplated hereby and ending immediately prior to the date of this Agreement.
Notwithstanding the foregoing, in the case of an Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only
apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such
information, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including
the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available
shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Disqualification Event</U>.
To the extent the Purchaser is one of the covered persons identified in Rule 506(d)(1), the Purchaser represents that no Disqualification
Event is applicable to the Purchaser or any of its Rule 506(d) Related Parties (as defined below), except, if applicable, for a Disqualification
Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. The Purchaser hereby agrees that it shall notify the Company promptly
in writing in the event a Disqualification Event becomes applicable to the Purchaser or any of its Rule 506(d) Related Parties, except,
if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this Section,
&ldquo;<U>Rule 506(d) Related Party</U>&rdquo; means a person or entity that is a beneficial owner of the Purchaser&rsquo;s securities
for purposes of Rule 506(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Access to Information</U>.
Such Purchaser acknowledges and agrees that other than materials that were prepared by the Company and expressly approved by the Company
for dissemination by the Placement Agent to the Purchaser, if any, , neither the Placement Agent nor any Affiliate of the Placement Agent
has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Such Purchaser further acknowledges and agrees that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to publicly available information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional publicly available information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges
and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any such information
or advice with respect to the Securities nor is such information or advice necessary or desired from the Placement Agent or any Affiliate
of the Placement Agent. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality
of the Securities. The Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such
Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement
Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Investment Company
Act Acknowledgment</U>. The Purchaser acknowledges that the Company&rsquo;s representation in Section 3.1(v) is based solely upon the
Company&rsquo;s operations and intended operations as they exist as of the date of this Agreement and the Closing Date, including the
Company&rsquo;s present intention to use the proceeds from the sale of Securities under this Agreement as described in Section 4.7, and
that the Company&rsquo;s status as an &ldquo;investment company&rdquo; is subject to change based upon one or more changes in the laws
or regulations regarding the Company&rsquo;s operations by one or more governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document, or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each of the
Purchasers acknowledge and agree that no party to this Agreement has made or makes any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in this Article III and the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Securities may only
be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant
to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as
contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration under the Securities Act. As a condition of transfer (other
than pursuant to an effective Registration Statement or Rule 144), any such transferee shall agree in writing to be bound by the terms
of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement
and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a legend in the form set forth in Section 3.2(g) hereof. The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) of Regulation D under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to Section 4.4 of this Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of selling stockholders thereunder.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Certificates evidencing
the Pre-Funded Warrant Shares shall not contain any legend (including the legend set forth in Section 3.2(g), (i) while a registration
statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Pre-Funded Warrant Shares pursuant to Rule 144, (iii) if such Pre-Funded Warrant Shares may be sold under Rule 144, without
the requirement for the Company to be in compliance with the current public information requirement under Rule 144 as to such Pre-Funded
Warrant Shares and without volume or manner-of-sale restrictions under Rule 144, or (iv) if such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The
Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion
of a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Pre-Funded
Warrant Shares, or if the Pre-Funded Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current
public information required under Rule 144, or if the Pre-Funded Warrant Shares may be sold under Rule 144 without the requirement for
the Company to be in compliance with the current public information required under Rule 144 as to such Pre-Funded Warrant Shares or if
such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), then such Pre-Funded Warrant Shares shall be issued free of all legends. The Company shall cause
its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect
the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date or
at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing the Pre-Funded Warrant Shares, as the case may be, issued with a restrictive
legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1. Certificates for Securities subject to
legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s
prime broker with the Depository Trust Company as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Pre-Funded Warrant Shares issued with a restrictive
legend. The Purchaser shall provide the Company written notice of a removal request (the &ldquo;<U>Request Notice</U>&rdquo;) at least
one (1) Trading Day prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) In addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each
$1,000 of Pre-Funded Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent)
delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day
five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four
days after the Request Notice date) until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and
deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to
the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of
all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then,
an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Pre-Funded Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Pre-Funded Warrant Shares and ending on the date of such
delivery and payment under this clause (ii).</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The Purchasers agree with
the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including
any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration
Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon
this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information;
Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) For at least two years
after the Closing Date, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or timely obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company with the Commission after the date hereof pursuant to the Exchange Act even if the Company is not then subject
to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) At any time during the
period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities of a Purchaser
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to
satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information
Failure until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no
longer required for that Purchaser to transfer the Pre-Funded Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall
be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public
Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3<FONT STYLE="font-size: 10pt"><SUP>rd</SUP></FONT>) Business Day after the event or
failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure
Payments in a timely manner, other than during the pendency of any bona fide dispute over whether an alleged Public Information Failure
has occurred, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months)
until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure,
and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities hereunder in a manner that would require the
registration under the Securities Act of the sale of the Securities hereunder or that would be integrated with the offer or sale of the
Securities hereunder for purposes of the rules and regulations of any Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby (including the entry into and material terms of the Asset Management Agreement), and (b) file a Current Report on Form 8-K, including
the Transaction Documents and such press release as exhibits thereto (and the Asset Management Agreement as an exhibit thereto, or a summary
of the material terms thereof), with the Commission within the time required by the Exchange Act. From and after the issuance of such
press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered
to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press
release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in
which case the disclosing party only shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) any registration statement contemplated by this Agreement and the Registration
Rights Agreement, (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Treasury
Management Agreement, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide or has provided any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that
the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. The Company acknowledges and agrees that any failure to timely
cleanse any material, non-public information shall entitle the Purchasers to seek injunctive relief and/or damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall deliver the net proceeds from the sale of the Securities hereunder to the Asset Manager on the Closing Date to be allocated
to fund the acquisition of cryptocurrency and the establishment of the Company&rsquo;s cryptocurrency treasury operations. The Company
shall use the net proceeds from the sale of the Securities hereunder as follows: (a) up to $1,100,000 shall be used to pay off the Company&rsquo;s
outstanding Indebtedness, (b) $4,400,000 shall be allocated to fund the Company&rsquo;s working capital and for general corporate purposes,
and (c) the balance of the net proceeds shall be used to acquire Dogecoin. The Company shall not use such proceeds: (a) for the redemption
of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding litigation, or (c) in violation of FCPA or
OFAC regulations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party, and such counsel shall provide regular and timely progress updates to the Purchasers. Any Purchaser
Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel. The Company may not settle, compromise or consent to the entry of any judgment
in any pending or threatened action in which indemnification may be sought by any Purchaser Party hereunder (whether or not any Purchaser
Party is an actual or potential party thereto), without the prior written consent of each such Purchaser Party (which will not be unreasonably
delayed or withheld) unless such settlement, compromise or consent provides for an unconditional and irrevocable release of each such
Purchaser Party from any and all liability arising out of such Claim. The Company will not be liable to any Purchaser Party under this
Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement
or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount
thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant
to this Agreement. Until the Authorization Amendment becomes effective, the Company shall not reserve for issuance the Pre-Funded Warrant
Shares issuable pursuant to any exercise of the Pre-Funded Warrants, Placement Agent Warrant Shares issuable pursuant to any exercise
of the Placement Agent Warrants, and Strategic Advisor Warrant Shares issuable pursuant to any exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market
on which it is currently listed, and the Company shall apply to list or quote all of the Pre-Funded Warrant Shares and the Strategic Advisor
Warrant Shares on such Trading Market prior to the Closing and promptly secure the listing of all of the Pre-Funded Warrant Shares on
such Trading Market prior to Closing. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Pre-Funded Warrant Shares and will take such other action as is necessary
to cause all of the Pre-Funded Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to maintain the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Management Appointments</U>.
The authorized size of the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) shall not exceed five (5) members. Effective as of the
Closing, the Board shall fill two (2) vacancies on the Board by appointing the individuals designated by HoD, it being acknowledged that
Alexander Benjamin Spiro and Timothy Stebbing are the initial individuals so designated and agreed to by the Board and HoD (each, together
with any successor designated in accordance with this Section 4.11, an &ldquo;<U>HoD Director</U>&rdquo;). For so long as HoD continues
to hold any shares of the Company&rsquo;s Common Stock, in the event that an HoD Director resigns, is removed, dies, or becomes disabled,
HoD shall have the right to designate one or more replacement directors reasonably acceptable to the Board (each, a &ldquo;<U>Replacement
HoD Director</U>&rdquo;). Upon receipt of written notice from HoD identifying (i) the HoD Director who has resigned, died, or become disabled,
and (ii) the individual nominated to serve as the Replacement HoD Director, the Board shall promptly evaluate the Replacement HoD Director
and confirm whether the Replacement HoD Director is reasonably satisfactory to the Board and upon such determination shall promptly (and
in any event within five (5) Business Days) deliver the written request contemplated by the applicable Director Agreement, accept the
tendered resignation (if applicable), and take all corporate action necessary to appoint the Replacement HoD Director to the resulting
vacancy. Concurrently with the Closing, the Company shall appoint (a) Marco Margiatto to the Company&rsquo;s management team and (b) a
finance executive reasonably acceptable to the Board and designated by HoD (the &ldquo;<U>Finance Executive</U>&rdquo;). For so long as
HoD continues to hold any shares of the Company&rsquo;s Common Stock, in the event that either Marco Margiatto or the Finance Executive
resigns, dies, or becomes disabled, HoD may, subject to the Board&rsquo;s reasonable approval, nominate one or more replacement individuals
reasonably acceptable to the Board, and the Company shall take all corporate action necessary to effect any such replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) From the date hereof until
thirty (30) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or
announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement
or amendment or supplement thereto, other than (A) a registration statement on Form S-8 in connection with any employee benefit plan;
provided, however, the Company will be permitted to enter into a sales agreement with the Placement Agent and such other sales agents
as the Placement Agent may designate (each, a &ldquo;<U>Sales Agreement</U>&rdquo;) providing for the sale of shares of Common Stock in
an &ldquo;at-the-market&rdquo; offering, and file any such prospectus supplement or registration statement with the Commission in connection
with such Sales Agreement or (B) the registration statement described in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding the foregoing,
this Section 4.12 shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain
the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form D; Blue Sky Filings</U>.
The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D under the Securities Act and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Acknowledgment of
Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Common Stock, which
dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction
Documents, including, without limitation, its obligation to issue the Pre-Funded Warrant Shares pursuant to the Transaction Documents,
are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may
have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions shall be required of the
Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be
required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in
order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants and shall deliver Pre-Funded Warrant
Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the prior written consent
of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in
accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly
use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.19 <U>Principal Market
Compliance</U>. In the event that the Principal Market requires the Company to (i) modify the terms of this Agreement or any of the transactions
contemplated hereby, or (ii) take any other action in connection with the transactions contemplated by this Agreement that necessitates
the cooperation, consent, or action of the Purchasers, including, without limitation, the execution of any amendment to this Agreement
or any related Transaction Documents, each Purchaser hereby covenants and agrees to cooperate in good faith with the Company and to take
all such actions, execute and deliver all such documents, and provide all such information as may be reasonably requested by the Company
to effectuate any such modification or action, in each case to the extent necessary to satisfy any concerns or requirements of the Principal
Market in connection with the transactions contemplated by this Agreement. Notwithstanding the foregoing, if any modification or action
required by the Principal Market would adversely affect a Purchaser&rsquo;s rights or obligations under this Agreement or the related
transaction documents, such Purchaser shall have the option, in its sole discretion, to either (a) agree to such modification or action,
or (b) terminate this Agreement with respect to itself upon written notice to the Company, whereupon this Agreement shall be of no further
force or effect with respect to such Purchaser (except for those provisions that expressly survive termination).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.20 <U>Information
Statement</U>. The Company shall file a definitive information statement on Schedule 14C with the Commission with respect to the August
22 Written Consent on September 2, 2025 (the &ldquo;Second Definitive Information Statement&rdquo;), and shall first mail the Second Definitive
Information Statement to its stockholders on or prior to September 5, 2025, in each case, in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">4.21 <U>Filing of Authorization Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company shall, as
promptly as practicable following the Closing Date (and in any event within twenty-one (21) days after the mailing of the First Definitive
Information Statement, prepare, execute and file with the Secretary of State of the State of Nevada the Authorization Amendment in form
and substance reasonably acceptable to HoD and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company shall use
its commercially reasonable best efforts to cause the Authorization Amendment to become effective under the laws of the State of Nevada
as promptly as practicable following its filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company shall not
take any action or omit to take any action that would materially delay, prevent or impair (i) the filing or effectiveness of the Authorization
Amendment, or (ii) the Company&rsquo;s ability to reserve and issue, upon exercise of the Pre-Funded Warrants, Strategic Advisor Warrants
or Placement Agent Warrants, the shares of Common Stock issuable thereunder in accordance with the terms of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.22 <U>Redemption
Right</U>. In the event that the Authorization Amendment is not effective within ninety (90) days from the date hereof, each Purchaser
shall have the right, exercisable for a period of fifteen (15) days to require the Company to (i) redeem the Pre-Funded Warrant purchased
by such Purchaser pursuant to this Agreement at a per Pre-Funded Warrant redemption price equal to the Per PFW Purchase Price minus the
Pre-Funded Warrant exercise price of $0.0001; and (ii) pay the amount of any unpaid liquidated damages owed (if any) to such Purchaser
pursuant to the terms of the Pre-Funded Warrants and the Registration Rights Agreement (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>. This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers, as well as fees and
expenses of the Asset Manager (including the expenses of its representatives) (the &ldquo;<U>Asset Management Fees</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered viaemail attachment at the email
address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City
time) on any Trading Day, (c) the second (2<FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>) Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment or waiver, by the Company, HoD and each Purchaser (or, prior to the Closing Date, the Company and each Purchaser). No waiver
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or
waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser, holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers&rdquo; (other than in respect of a transfer pursuant to an effective registration statement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Third-Party Beneficiaries</U>.
The Placement Agent shall be the third-party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered or by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file or DocuSign, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; or DocuSign signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise of a Pre-Funded Warrant,
the applicable Purchaser shall be required to return any Common Stock subject to any such rescinded exercise notice concurrently with
the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s
right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a replacement warrant certificate
evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers. Each Purchaser shall be entitled to
independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for
such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated Damages</U>.
The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and number of shares of Common Stock or Securities, in any Transaction Document shall be subject to adjustment for any stock
split, subdivision, dividend, distribution payable in shares of Common Stock (or other securities or rights convertible into, or entitling
the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring
after the date hereof and prior to the Closing, of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <B><U>WAIVER OF JURY
TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY.</U></B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>CleanCORE SOLUTIONS, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; width: 3%">By:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; width: 37%"><I>/s/ Clayton Adams</I></TD>
    <TD STYLE="vertical-align: top; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 55%">CleanCore Solutions, Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: Clayton Adams</TD>
    <TD>&nbsp;</TD>
    <TD>Attn: Clayton Adams, CEO</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: CEO</TD>
    <TD>&nbsp;</TD>
    <TD>5920 S 118<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> Circle&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Omaha, NE 68137</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>E-Mail:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4">With a copy to (which shall not constitute notice):</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">Bevilacqua PLLC<BR> 1050 Connecticut Avenue, NW, Suite 500<BR> Washington, DC 20036<BR> Attn: Louis A. Bevilacqua, Esq.<BR> Email:</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">CLEANCORE
SOLUTIONS, INC.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 60%">Name of Purchaser: Brag House Holdings, Inc.</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 40%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><I>Signature of Authorized Signatory of Purchaser: /s/ Lavell Juan Malloy, II</I></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Name of Authorized Signatory: Lavell Juan Malloy, II</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Title of Authorized Signatory: Chief Executive Officer</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Email Address of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Address for Notice to Purchaser: </TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Brag House Holdings, Inc. 45 Park Street, Montclair, NJ 07042</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Address for Delivery of Securities to Purchaser
(if not same as address for notice):</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subscription Amount for Securities purchased
hereunder: <U>$4,000,000</U>_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Portion of Subscription Amount paid in Dogecoin
$_________________ (HoD Contribution Only)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per PFW Purchase Price: $<U>1.00</U>_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrants: <U>4,000,000</U>__________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advance Payment of Exercise of Pre-Funded Warrants:
________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant Shares (Beneficial Ownership Blocker <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT> 9.99%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: <U>87-4032622</U>_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ea025642801ex10-2_brag.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 1, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of September 1, 2025, between CleanCore Solutions, Inc., a Nevada corporation
(the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of September 1, 2025, between the Company and the Purchasers named therein (the &ldquo;<U>Purchase
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Definitions</U>. Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the class B common stock of the Company, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Effectiveness Date</U>&rdquo;
means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier of the (A) the
30<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> calendar day following the Filing Date and (B) the 2nd Business Day after the date
the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed
or will not be subject to further review (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<FONT STYLE="font-size: 10pt"><SUP>th
</SUP></FONT>calendar day following the Filing Date) and (ii) with respect to any additional Registration Statements that may be required
to be filed by the Company pursuant to this Agreement, the earlier of the (A) 45<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> calendar
day following the date on which the Company was required to file such additional Registration Statement and (B) 2nd Business Day after
the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be
reviewed or will not be subject to further review (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<FONT STYLE="font-size: 10pt"><SUP>th
</SUP></FONT>calendar day following the Filing Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Effectiveness Period</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Event Date</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Filing Date</U>&rdquo;
means, with respect to the Initial Registration Statement required hereunder, the earlier of (i) the 20<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>
calendar day following the Closing Date, or (ii) 1 Business Day after the Stockholder Approval becomes effective. With respect to any
additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), &ldquo;Filing Date&rdquo; means the
earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the
Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Indemnified Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Indemnifying Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Initial Registration
Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Plan of Distribution</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Registrable Securities</U>&rdquo;
means, as of any date of determination or subsequently acquired, (a) all the Pre-Funded Warrant Shares, (b) all the Placement Agent Warrant
Shares, (c) all Strategic Advisor Warrant Shares, and (d) any securities issued or then issuable upon any share split, dividend or other
distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities
shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another,
Registration Statement hereunder with respect thereto) to the extent (a) a Registration Statement with respect to the sale of such Registrable
Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been transferred, exchanged
or disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously
sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and
without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise,
conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated
by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement
or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Selling Shareholder
Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff, (ii) the Securities Act and (iii) any other rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) On or prior to each Filing
Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities
that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule
415. Each Registration Statement filed hereunder shall be on Form S-1 or such other appropriate form in accordance herewith, subject to
the provisions of Section 2(e) and shall contain substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex
A</U> and substantially the &ldquo;<U>Selling Shareholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>,
that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent.
Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement
(including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the
filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration
Statement continuously effective under the Securities Act, and to be supplemented and amended to the extent necessary to ensure that such
Registration Statement is available or, if not available, that another Registration Statement is available, for the resale of all the
Registrable Securities held by the Holders until the date that all Registrable Securities covered by such Registration Statement (i) have
been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144
and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined
by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and
the affected Holders (the period commencing on the Effectiveness Date and ending on the later of the dates set forth in clause (i) or
(ii) of the provision, the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration
Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via facsimile or by
e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness
with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.
(New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to
file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Notwithstanding the registration
obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result
of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees
to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration
Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission,
on Form S-1 or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions
of Section 2(e); with respect to filing on Form S-1 or other appropriate form, and subject to the provisions of Section 2(d) with respect
to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such amendment, the Company shall be obligated
to use reasonable best efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance
with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure Interpretation Question 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Notwithstanding any other
provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or any SEC Guidance
sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a
secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of
all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities,
the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) First, the Company shall
reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) Second, the Company shall
reduce Registrable Securities represented by Pre-Funded Warrant Shares, Placement Agent Warrant Shares and Strategic Advisor Warrant Shares
(applied, in the case that some Pre-Funded Warrant Shares, Placement Agent Warrant Shares and Strategic Advisor Warrant Shares may be
registered, to the Holders on a pro rata basis based on the total number of unregistered Pre-Funded Warrant Shares, Placement Agent Warrant
Shares and Strategic Advisor Warrant Shares held by such Holders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">In the event of a cutback
hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such
Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company
will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or
to registrants of securities in general, one or more registration statements on Form S-1 or such other form available to register for
resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, and to use
its commercially reasonable efforts to cause the Commission to declare such registration statement covering the Registrable Securities
that were not registered for resale on the Initial Registration Statement, as amended, effective as soon as practicable after the date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) If: (i) the Initial Registration
Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders
the opportunity to review and comment on the same as required by Section 3(a) herein or the Company subsequently withdraws the filing
of the Registration Statement, for reasons other than at the request of the Holders of a majority in interest of the Registrable Securities
to withdraw the Registration Statement, the Company shall be deemed to have not satisfied this clause (i) and any such event or circumstance
shall thus constitute an &ldquo;Event&rdquo; as defined below), or (ii) the Company fails to file with the Commission a request for acceleration
of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5)
Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration
Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of a Registration
Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in
respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that
such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering
for resale all of the Registrable Securities, subject to the cutback limitations set forth in Section 2(c) of this Agreement, is not declared
effective by the Commission by the Effectiveness Date of the Initial Registration Statement (provided that, if the Registration Statement
does not allow for the resale of Registrable Securities at prevailing market prices (i.e., only allows for fixed price sales), the Company
shall have been deemed to have not satisfied this clause and any such event or circumstance shall thus constitute an &ldquo;Event&rdquo;
as defined below), or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain
continuously effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted
to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than
an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure
or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on which such Event occurs,
and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date
which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar
day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the
Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if
the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder
an amount in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure. If the Company fails to
pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest
thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing
daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The
partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the
cure of an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) The Company shall register
the resale of the Registrable Securities on Form S-3 under the Securities Act (or in the event that the Company is ineligible to use such
form, such other form as the Company is eligible to use under the Securities Act provided that such other form shall be converted into
an S-3 as soon as Form S-3 becomes available to the Company), provided that the Company shall maintain and effectiveness of and update
as required the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable
Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) Notwithstanding anything
to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any Underwriter
without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Registration Procedures</U>.
In connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Not less than five (5) Trading
Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus
or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference),
the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated
or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel
and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective
counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act, provided that the Company shall
redact any sections of such documents that may contain material non-public information unless the Holder consents in writing to receive
such information and agree to hold it in confidence. The Company shall not file a Registration Statement or any such Prospectus or any
amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith,
provided that, the Company is notified of such objection in writing no later than five (5) Trading Days after the Holders have been so
furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus
or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this
Agreement as <U>Annex C </U>(a &ldquo;<U>Selling Shareholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading
Days prior to the Filing Date or by the end of the fourth (4<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Trading Day following
the date on which such Holder receives draft materials in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) (i) Prepare and file with
the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection
therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for
the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale
under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required
Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424,
(iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement
or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) If during the Effectiveness
Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration
Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional
Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Notify the Holders of Registrable
Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend
the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below,
not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later
than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration
Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo; of such Registration
Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement
or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state
governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of
the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of
a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv)
of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification
of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose,
(v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible
for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents
so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development
with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the
best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>, <U>however</U>,
that in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company
or any of its Subsidiaries and the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of
its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information.
In the event that any notice or communication provided to a Holder contains or is deemed to contain material, non-public information regarding
the Company or any of its Subsidiaries, the Company shall, as promptly as practicable and in any event within one (1) Business Day, publicly
disclose such information in a manner compliant with Regulation FD, so as to cleanse such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Use its best efforts to
avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration
Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale
in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) Furnish to each Holder,
without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements
and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and
all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after
the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or successor thereto)
need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Subject to the terms of
this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling
Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement
thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) The Company shall cooperate
with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA Corporate
Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay the filing fee required by
such filing within two (2) Business Days of receipt of a request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Prior to any resale of Registrable
Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection
with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities for the resale
by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in
writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and
all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by
each Registration Statement, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where
it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file
a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) If requested by a Holder,
cooperate with such Holder to facilitate the timely preparation and delivery of certificates, or book-entry notification as applicable,
representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates or book-entry
notification shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable
Securities to be in such denominations and registered in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) Upon the occurrence of any
event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&rsquo;s
good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to
suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of
such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.
The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration Statement and
Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed
60 calendar days (which need not be consecutive days) in any 12-month period. The Company shall use its best efforts to minimize the duration
and frequency of any such suspension, and shall not exercise its right to suspend sales for the purpose of limiting or restricting any
Holder&rsquo;s ability to sell Registrable Securities for competitive or other non-disclosure-related reasons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) Otherwise use commercially
reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act,
including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof,
with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness
Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver
a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to
facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) The Company shall use its
reasonable best efforts to obtain and maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of
the resale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) The Company may require
each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such
Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During
any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities
solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated damages
that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay
shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) Notwithstanding any other
provisions of this Agreement to the contrary, the Company shall cause (i) each Registration Statement (as of the effective date of Registration
Statement), any amendment thereof (as of the effective date thereof) or supplement thereto (as of its date), (A) to comply in all material
respects with applicable SEC Guidance and (B) not to contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein not misleading, and (ii) any related Prospectus (including
any preliminary Prospectus) and any amendment thereof or supplement thereto, as of its date, (A) to comply in all material respects with
applicable SEC Guidance and (B) not to contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, not misleading; provided, however, the Company shall have no such
obligations or liabilities with respect to any written information pertaining to any Holder and furnished in writing to the Company by
or on behalf of such Holder specifically for inclusion therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p) The Company covenants that
it will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted
by the Commission thereunder (or, if the Company is not required to file such reports, it will, upon the reasonable request of any Holder,
make publicly available such necessary information for so long as necessary to permit sales pursuant to Rules 144, 144A or Regulation
S under the Securities Act), and it will take such further action as any Holder may reasonably request, all to the extent required from
time to time to enable the Holders, to sell Registrable Securities without registration under the Securities Act within the limitation
of the exemptions provided by (i) Rules 144, 144A or Regulation S under the Securities Act, as such rules may be amended from time to
time, or (ii) any similar rule or regulation hereafter adopted by the Commission. Upon the reasonable request of a Holder, the Company
will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Registration Expenses</U>.
All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence
shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&rsquo;s
counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings
required to be made with any Trading Market on which the shares of Common Stock are then listed for trading, and (C) in compliance with
applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements
of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), and (D) if not previously
paid by the Company with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales
of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage
commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for
Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v)
Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained
by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall
be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this
Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties),
the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any
securities exchange as required hereunder. In no event shall the Company be responsible for any broker, underwriter or similar commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Indemnification by the
Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless, to the fullest extent
permitted by applicable law, each Holder, the officers, directors, members, partners, agents and employees, brokers (including brokers
who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call), investment
advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack
of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) and the officers, directors, members, shareholders, partners, agents and employees (and any other
Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each such controlling Person, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation,
reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred in investigating, preparing or
defending against any litigation, commenced or threatened, or any claim, arising out of or relating to (1) any failure by the Company
to comply with the covenants and agreements contained in this Agreement, (2) <FONT STYLE="background-color: white">any failure to register
or qualify Registrable Securities in any state where the Company or its agents have affirmatively undertaken or agreed in writing that
the Company (the undertaking of any underwriter being attributed to the Company) will undertake such registration or qualification on
behalf of the Holders of such Registrable Securities (<U>provided</U> that in such instance the Company shall not be so liable if it has
undertaken its reasonable best efforts to so register or qualify such Registrable Securities), (3)</FONT> any untrue or alleged untrue
statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the
circumstances under which they were made) not misleading or (4) any violation or alleged violation by the Company of the Securities Act,
the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations
under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon
information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that
such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed
and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or
supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence
of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable
Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for
use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(c). The Company shall notify the Holders
promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by
this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made
by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance
with Section 6(f).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Indemnification by Holders</U>.
Each Holder shall, severally and not jointly, indemnify and hold harmless, to the fullest extent permitted by applicable law, the Company,
its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities
Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, from and against
all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of a material fact
contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or
arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the
statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not
misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished
in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent,
but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Shareholder Questionnaire
or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly
for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus
or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the
sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Conduct of Indemnification
Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an &ldquo;<U>Indemnified
Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;)
in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably
satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof, provided that
the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant
to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination
is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party. The
Indemnified Party shall provide the Indemnifying Party with regular and timely progress updates with respect to any Proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">An Indemnified Party shall
have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably
believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall
not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of
any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release
of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Subject to the terms of this
Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in
connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that the Indemnified
Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which
such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further
review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Contribution</U>. If
the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless
for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion
as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements
or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying
Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue
statement of a material fact or omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying
Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent
such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject
to the limitations set forth in this Agreement, any reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection
with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for
in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other
method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The indemnity and contribution
agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Remedies</U>. The failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party to exercise such right or remedy,
shall not operate as a waiver thereof. In the event of a breach by the Company or by a Holder of any of their respective obligations under
this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and
under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each
of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason
of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>No Piggyback on Registrations;
Prohibition on Filing Other Registration Statements</U>. Except as disclosed in Section 3.1(w) of the Purchase Agreement, neither the
Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company
in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements until
all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided
that this Section 6(b) shall not prohibit the Company from (i) filing amendments to registration statements filed prior to the date of
this Agreement so long as no new securities are registered on any such existing registration statements, (ii) filing registration statements
on Form S-8 or (iii) filing registration statements related to an &ldquo;at-the-market&rdquo; offering of the Sales Agreement or New Sales
Agreement as permitted by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Discontinued Disposition</U>.
By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of
any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable
Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company that the use
of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure
that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that any periods during
which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions
of Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Piggy Back Registrations</U>.
If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the Registrable Securities
and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account
or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated
under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition
of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock option or other employee benefit
plans, then the Company shall deliver to the Holder a written notice of such determination as soon as practicable, and in no event less
than 15 days prior to the date of filing of such registration statement, and, if within ten (10) days after the date of the delivery of
such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all Registrable Securities
such Holder requests to be registered; provided, however, that the Company shall not be required to register any Registrable Securities
pursuant to this Section 6(d) that are eligible for resale pursuant to Rule 144 (without volume restrictions or current public information
requirements) promulgated by the Commission pursuant to the Securities Act or that are the subject of a then effective Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Amendments and Waivers</U>.
The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers
or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and
the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable
Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver disproportionately
and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall
be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in
compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro
rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such
Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter
that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other
Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; <U>provided</U>,
<U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions
of the first sentence of this Section 6(e). No consideration shall be offered or paid to any Person to amend or consent to a waiver or
modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.
Notwithstanding anything above to the contrary, an amendment, modification, supplement, waiver or consent to (i) extend either the Filing
Date and/or the Effectiveness Date shall require the unanimous vote of the Holders and (ii) Section 2(d) shall require the consent of
a Holder to be effective against such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Successors and Assigns</U>.
This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall
inure to the benefit of each Holder. The Company may not assign (except by merger, subject to any successor entity assuming in writing
all of the obligations of the Company under this Agreement) its rights or obligations hereunder without the prior written consent of all
of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner
and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>No Inconsistent Agreements</U>.
Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries,
on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing
the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Neither the Company nor any of
its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any
Person that have not been satisfied in full, other than with respect to the registration rights granted to the holders of the Placement
Agent Warrants (as defined in the Purchase Agreement).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Execution and Counterparts</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file or Docusign, such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; or Docusign
signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <U>Governing Law</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <U>Cumulative Remedies</U>.
The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <U>Severability</U>. If
any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find
and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant
or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms,
provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) <U>Headings</U>. The headings
in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect any of
the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) <U>Independent Nature of
Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations of
any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder.
Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto
or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or
entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations
or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting
in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder
shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall
not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement
with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder,
and was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly
understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the
Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 37%"><I>/s/ Clayton Adams</I></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Name: Clayton Adams</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Title: &nbsp;Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[SIGNATURE PAGE OF HOLDERS FOLLOWS]</I></P>




<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO CLEANCORE SOLUTIONS, Inc., RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%">Name of Holder: Brag House Holdings, Inc.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><I>Signature of Authorized Signatory of Holder: /s/ Lavell Juan Malloy, II</I></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name of Authorized Signatory: Lavell Juan Malloy, II</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title of Authorized Signatory: CEO</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Plan of Distribution</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each selling shareholder (the
&ldquo;<U>Selling Shareholder</U>&rdquo;) of the securities and any of their donees, pledgees, transferees, assignees and successors-in-interest
may, from time to time, sell, transfer or otherwise dispose of any or all of their securities covered hereby on the principal trading
market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These dispositions
may be at fixed or prices at prevailing market prices at the time of sale, at prices relating to the prevailing market price, at varying
price determined at the time of sale or at negotiated prices. A Selling Shareholder may use any one or more of the following methods when
disposing securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">block trades (which may include crosses) in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange and/or secondary distributions;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">directly to purchasers, including through specific bidding, auction or other process in privately negotiated transactions;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">underwritten offerings;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">settlement of short sales;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">in transactions through broker-dealers that agree with the Selling Shareholders to sell a specified number of such securities at a stipulated price per security;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise, including, without limitation, any securities sold, borrowed or purchased by a counterparty to a Selling Shareholder as a hedge to such transaction;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">through the distribution of the shares of common stock by a Selling Shareholder to its employees, partners (including limited partners), members or stockholders;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">through delayed delivery requirements;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">a combination of any such methods of sale; or</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">any other method permitted pursuant to applicable law.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders may,
from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time
to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), amending the list of selling stockholders to include the pledgee, transferee,
or other successors in interest as selling stockholders under this prospectus. The Selling Shareholders also may transfer the shares of
common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Shareholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Shareholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Shareholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Shareholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Shareholders has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Shareholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Shareholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the shares of Common Stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Shareholders will be subject to applicable provisions of the Exchange Act
and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the shares of Common
Stock by the Selling Shareholders or any other person. We will make copies of this prospectus available to the Selling Shareholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 16; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SELLING SHAREHOLDERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of Common Stock
being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders,
upon exercise of the pre-funded warrants. For additional information regarding the issuances of those shares of Common Stock, see &ldquo;Private
Placement&rdquo; in the Purchase Agreement. We are registering the shares of Common Stock in order to permit the selling shareholders
to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the pre-funded warrants,
the selling shareholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and pre-funded warrants, as of ________, 2025, assuming exercise of the pre-funded warrants held by the selling
shareholders on that date, without regard to any limitations on exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of Common Stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement&rdquo; described above and (ii) the maximum
number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised
in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of
the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration
right agreement, without regard to any limitations on the exercise of the pre-funded warrants. The fourth column assumes the sale of all
of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the pre-funded
warrants, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together
with its affiliates and attribution parties, to beneficially own a number of Ordinary Shares which would exceed 4.99% or 9.99%, as set
forth in the warrants of such selling shareholder, of our then outstanding shares of common stock following such exercise, excluding for
purposes of such determination shares of common stock issuable upon exercise of the warrants which have not been exercised. The number
of shares in the second column does not reflect this limitation. The selling shareholders may sell all, some or none of their shares in
this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 21%"><B>Name of Selling<BR>
 Shareholder</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 21%"><B>Number of shares of<BR>
 Common Stock Owned<BR>
 Prior to Offering</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 31%"><B>Maximum Number of shares of<BR>
 Common Stock to be Sold Pursuant <BR>
to this Prospectus</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 21%"><B>Number of shares of<BR>
 Common Stock Owned <BR>
After Offering</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 17; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B><U>Annex C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CLEANCORE
SOLUTIONS, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Selling Shareholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of shares of Common Stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of CleanCore Solutions, Inc., a Nevada corporation (the
&ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the
&ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale
under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in
accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling shareholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling shareholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned beneficial owner (the &ldquo;<U>Selling
Shareholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby provides the following information
to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>QUESTIONNAIRE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in"><B>1.</B></TD>
    <TD STYLE="text-align: justify"><B>Name.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(a)</TD>
    <TD>Full Legal Name of Selling Shareholder</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(b)</TD>
    <TD STYLE="text-align: justify">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(c)</TD>
    <TD STYLE="text-align: justify">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><B>2.</B></TD>
    <TD><B>Address for Notices to Selling Shareholder:</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Telephone:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 40%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Fax:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 40%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Contact Person:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 40%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><B>3.</B></TD>
    <TD STYLE="text-align: justify"><B>Broker-Dealer Status:</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">(a)</TD>
    <TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">(b)</TD>
    <TD STYLE="text-align: justify">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">Note:</TD>
    <TD STYLE="text-align: justify">If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">(c)</TD>
    <TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">(d)</TD>
    <TD STYLE="text-align: justify">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Note:</TD>
    <TD STYLE="text-align: justify">If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><B>4.</B></TD>
    <TD STYLE="text-align: justify"><B>Beneficial Ownership of Securities of the Company Owned by the Selling Shareholder.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">(a)</TD>
    <TD STYLE="text-align: justify">Type and Amount of other securities beneficially owned by the Selling Shareholder:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><B>5.</B></TD>
    <TD STYLE="text-align: justify"><B>Relationships with the Company:</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned agrees to promptly notify the
Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any
time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of
any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By signing below, the undersigned consents to
the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration
Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will
be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus
and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 5%">Date:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1pt; width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 15%">Beneficial Owner:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1pt; width: 35%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 55%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>tbh-20250902.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qRZo7xRiXhun8uNbXQsSaCDSaPtypR1KYkxs2t5HRnaLyMtHMGBqCzaXfuWgREA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:TBH="http://braghouse.com/20250902" elementFormDefault="qualified" targetNamespace="http://braghouse.com/20250902">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://braghouse.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tbh-20250902_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tbh-20250902_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tbh-20250902_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>tbh-20250902_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="tbh-20250902.xsd#Cover" roleURI="http://braghouse.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://braghouse.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brag House Holdings, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001903595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-4032622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">45 Park Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Montclair<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">398-2845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TBH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0256428-8k_brag.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://braghouse.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0256428-8k_brag.htm">ea0256428-8k_brag.htm</File>
    <File>tbh-20250902.xsd</File>
    <File>tbh-20250902_lab.xml</File>
    <File>tbh-20250902_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0256428-8k_brag.htm": {
   "nsprefix": "TBH",
   "nsuri": "http://braghouse.com/20250902",
   "dts": {
    "inline": {
     "local": [
      "ea0256428-8k_brag.htm"
     ]
    },
    "schema": {
     "local": [
      "tbh-20250902.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tbh-20250902_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tbh-20250902_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://braghouse.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0256428-8k_brag.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0256428-8k_brag.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-25-085657-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-085657-xbrl.zip
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M VP64";:?R<_W[I4/.\HZQ8P_N(*]SS(UE5..VRZ:2T*"6PK2E[+[T)9V-E
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M1,2R'HC&D/'(R3+##Z26.%H[FC0-?53#QF_<IQD/K-Z_Y83UQ/Y8*\_7#"[
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M8*-/"(U'&,2@V_KR/K,8+>-1HG..@Z*S[;=T*VFG2Z1),O--^&/@,*D$5>L
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M=SYEAB,U-3YI4ZL3.+RJU)TEX&EI9$40JSB4D2TQ1RZ*_RALE]6]!YJV CJ
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ME1(**.<LC$Y31L.5J2DK=C"K-3@C)!_3.\0N8%'JR'PVRFN@AFWQXPCWQ'W
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M(L0B::S>@E?Q"EN9#Y")"30(QP?SG#KSX^5LG^Q<[?J*SS"+3,7BCE[SO'2
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MG*M,_SG4MCRPMIF4*4:BU-JOZMD3U ]/C64AO#,Q ZM2=DJ90OC?$EN_H/T
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M@[OMA5*Z;9&3^A9^%#^)N [7),NT'0T^XO:64/?/P7S.J>B(P+84&Z4@3UK
MH;F6:E*\7BZRH$,#1W98DK:,_T'W/T-8],&VE[RS1 <]#FMH'GN@M\6H,F+
ML T]73AZF1(8IVWUP1BS14Q@7HZCCZ;X)RC?B\2'[7AI7</,W[FQ*X*6@O]&
MN*E77MSVIW5<J*9(>P#8]?S:',J]T6U1F\=[Z(UL<KWK2IM7<GZR#UOWI*@;
MKD5$MJUVKQGJ(WB!,A&AG"MHU#>+$PF50KZHB5R_2HP+V61!F-IB>_9; ; 1
MBX.TAMD2 (,Q6>*%\U%7<@@P++@12:R.;IYK-I_55)K1M=(23RHYV@_Z%RRW
MN:ZFLV )9;Q(U="?H/']1H="6ZMNRC?T7]Z8Y!_Y[;78@!#R0V_5)II\EEV
M(8TD%^&2[EZ;#.MRP+=GMDG'9D0(543YJ/N^!KH<=(OA-1AORTDMI,^8Y<#"
MBZVND"Q%3_=>ER=@ ZTBNT!&]I7:*$//,>$L69ZEAK0*ID,"9(*; QPY+L<A
M1R(6/6G'W;EC<!GR_3ECV>*B;0U0Y@PYI9:4!R'6:DCEUBU4I,[6$]E8*DU
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M02-=<CQ9V"QI0C8_J,A_Q<F;=%)",,D-1'BS4LT<D+?6'%5IX*_%_2YU=Y?
M1H3(V8*T\]DU%(Y6<EH0$ELVK04+V9/1QK#=.V\M1>9';+R SGKUNL- U)M
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MT$H@:1'+#J5E59!=/]9HV=R9'Y:/H.5LY^F35K,.+'A^-?#C$>Z"M:L>2G
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M,?SOR\?PV5=K@THSR5R/,F\&)C@GN;1W>X.]A()(KE8,R^L9TB5#S^H,.S)
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M/D&IA'>8)IA ;V 0X6TIWS&;T,@;)]^P,]>\V>!Y)?V3)H'V-5V+OT^:U:)
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MM&!\QW_4#7[5@(NTPG");"&CXF'&&_1:QJ,3A\@.D@]=V+R_S=9@TZ#O=8:
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M^VAPSA#T@O>V1[(:VL,4/P\4P"X=Q%,$V.IE/O(99]Y(8AV_VEB?*/TC**'
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M/P=X"QI?>($Y%91+N9. WVQRJU]JV!ZCVUSW7H588?>R#]?F3(BYK1AQN,(
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MJU@@[?7X. /9. ='JIS=@3FLZD?H3[7Y-T\"E>.ZG*J2WOZJ\LRP*4K!HC:
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M_4BCX)L;C8(#FI$7XI8^JE^%(N0.7AR_/9Q=&JI8&Q%3L_C]WG32TV0P:+U
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MGWJ<HNVV8_'/4[>'3+:68G^)XPNC-1.G'>_%%H[5?<7<'1I%0%KMISGQX*1
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M<VI5:4_9B$_>6!,],ZH8*[$MR2%7'BO+'1L6J;(K#A.L<AN N;X5F*],8(R
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MD!E3O_H Y?&(ATTS&X9+N_K3WE1Z5&H!A?6T45..%#4BF\@0"8*Y8UKLMU!
M&"-.:@-FE<CX40\X:3\R""2*0BN+P8189?EB$).N!!F1@?VQ7H"5DILN/\:1
MY=HY=!_>$<<WZE/QAR)$H"X1]HRS*">413%J2;^G<(GGE&,M*N[JI/KJO+5O
MG_R:2L<P//'9<5XN,71C<%WA^P8;:D!ERW97#=,B"33KPNNYEP9A%VK)$KUB
MK>);=@>Y_U8N@L!4VU)Z2-BU>>(*22C9Z,42@GD>CTX,6*CW93V]R#*SG_R>
M\R3 \N*TKHIH?DGM6=OMOL_W(46C+>BE&70IA[4)1B!28G4=>QQ<Q(2I-IR>
MM5(E2E+@U6B:6)%&/6&:(8PA\\GQP[W>D^-C^+ W"+Q]$N*%#WG^UG0,W]_&
MDFTL^?O;6/(&D?K<% Q//RL%P\G1RY?'KWY.3GXY?'LD;%&?;P"?G*MEHT,>
M/^G'(^Z#Y@4S';*A\4X+BJ)B[%FU%RR:9NV:K,5^9XC@\8=XM3Z5HM>/1]2N
M%<S6>EHT]LB A]Z9KRFN>26M_?:3%WA(.M)T[1&Q\V9B=/3D<FI.2QQ,?$:0
M[L'&[-YP8==X9+L+FLA=;R-!.J)QJHS9;J.$<5.+^BD(/)C!:[TS0W%[1C.I
M&\ZY%PT>J!T8USY:0)B0-@8=PU,NBM4&L)9MWM.=])1-NJB(V+:/%QD3=,!:
MP QD"V%[ #L+GTW'^[K1X<]5UN"+8V'(-;C\NQ@R:VEGG.6+ZHK@6622@BL7
MW8O8F8(,PWZ1=["DK9?=]%&T7G_WT=*5C$M>D6%NO2S=<'6-3L\C[*A >UA,
M8-[#%9,F9Q1<1B@#-BM6[R%BV"^_,=D5;N;_7_Z7)O?NWGN8N@;+6R@=V^=+
MS1 UGU"6NW0"P4!5FL2C23IHI+3=+LK]15%W)4FFM*LP(P>6[XP,G&$[-KO'
M\;)V:APFO45CC7:#9LG]!WLX\^>PMVO:V!3H:F*IH_52AW)97=!8>G;R9@/#
MG,7^F9UTCNQ9WDSKX@Q)@Y"#G70$Q3DI_9:]+Y;KY7BT48%9&R9JI= YYVD<
M35;4".39ZXMN%0MU,S4WG!$:FKKR.3YY0_8T0PS#$ALZ<MGY"A-\5O'/F'6$
M4B]J=2DFR,M*.;-">N)A_]B9*L<\>I:R/LX:JV:W>["*Q9B^W.;M;72=HLHZ
M?C-#$3:\^;8Y96'RCNX%QB.23R>>6ZI6RB)L8TRB,IICZ\8+HXT8R]&XD$70
M\MZ*R&;K>2!,OF-:Z3<;SB%%U%V2\4B=UU$&.1,%M<N*-[#[2'0%/)KZTU)>
MW%S(;16YB9!4$4>,#M/&6G(OQ.DRAWV"4B\Y\M8%:Z78(.7LC6_>P LXC?+:
MT%*=L-Q(^VP:$J(Z080>[/_XX[<8.OL1_Y(*DG0\LE!2[TU=*73D);!^=DT3
M77KZID>O.9XS;\92;BAK>D^-1QK63E?Z6_R#M*93@30C?O=XJQ%YAW:/#)D5
MWR2U:7^#@*%-YU0#WRRZ52W\*4/>/U/A4A+BR%:CF$<+;MQP2.S#[G!'483V
M<5^.HZ]@S_]%.:F#:.39<&,+$UF44=T[^)8",H9<6>+BCY]2+9C'0/ETN,_%
MO6^'J]\^SC"[UH@,U;.)7Z,?)5^\,3'WUR*27_9-[LN;_,H&5K+E&W$B_ 2S
MHF_,R<G7=>'S?[VEDE<YI":[G76Z>:>2C?UG/MN'?X^Q?Y+V+&2]/D*%_95D
MFCY@0%NGGGZX33W9U-,/.YQZ^L)"WY^+BEM(.C_U['.EA[9L>Z)[G(U'06\3
M'N?GZ-+R6;HJP+O&*%1>52T2.Z$#]I_8[!7LZ3(KZOQOS:..?@JCDI'#?-8M
M-_:#59ZU$92'F[Z%Z(@Y+$5(MOYLD6?E,RRL /O+%,]P YT,7N\RFR$2!+Q
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MQ[1^"\KP%AY /H^^ABP9?E^"!MW0E.L$!I7)ITY'X4^--6LB-Q'.;0_4,#*
MX)>CCQF@^>)\#CRR'?-_/7B0O,RS8O84N.Q%]@P^_.LR@_L!CR8/'IB(S,'1
M3V9R/.2#MEK (X\Q)B._F50MZ/%/DV_Q=Q-@+5EM?[=7P.V"P;^!>395D<]@
M"L%R046X L:\R:J[$3 ["9K63F16\#N]X<\?PI(BJYO -7_[@&V!IW"C<4OT
MI[^-?!IW0:]''4KOD&K?'^+&\U[_^<F/7%X3W^5%.K9XN\X]-=S:Z]97[[/L
M[!VR<XZ)  %=D7K1?>DO*F+@L5$PKU-R CSPK/_AP!IW9!K"A]  J-;;D6/4
M(QNZ/FVQ0ITW26<<BH+'\6\Y7 EQDHFJ:YAP?.YD]O5.?N3,=:V>PH^+-!</
MDI6&(FS!V&I8](H.@[_,/+^4VU^M3)BXA_$B2L#.; J8F\N:]JK.<"O%4S8F
M$QR&$)DW=OH"[#E-L_>PC;:[2J9Y/5U>-22V84MJB8%9D7P#(KJIT+G.,ZXS
MU'&0Y2]+&B/X<F<G(W$>M[>R_^-XS MT>2MP W.[2]_6U+XKPH9N^Y1N^[XQ
M5#U//UYXM>FHH*1%4WF.ZGZG#U$2:383(]I)PY(SZ-C&5CWI^K%T7$_1MD2\
MD;OT*6)>&! 5$7(@5Q/4L=FU,\NO<]) _N_6[H.]4;+UK]%_X^^W=M&_A_3S
M](,="_WO(XRP;') #Q[_W9=1GSI[Q'SE&G,.P*8VTP59^]7FF24[VT\HI 0;
MFOPS^0V9)#8!$:2!L[>>DN\+C_6GGW=?&]58JY/YU54VRX%Y%2OD:--L9E1^
M8QS=[A3*A2/&_M20_0-ZQJ5S+J)F[$QET,LQ-D%<R7EXTI%)82#E&C5Q#I.P
M]IQZBX!+M?7X XRBO^E)S&J1$3>&!^5F L=?%FE-%@"Y8RH8P-S.P!-XNH1]
M^W9G![4&^,(IO4HS./[Q#,VPJV5Q0;:+B[[,LQE%6E6@IDAO&G1D\F:KN8[9
MB9FV,E=MFS%O #TC)W%MPAP?DQSP-/Z'A]D#T?7:*3Z!)23CPTZ7TWP!BPU,
MJ)0"2B!WF0GM%56%'.PB>;7]>CO9<G+*_L7+RTBM&X?=ZGI#K+.2R45MV.\A
M=4M[LR6Y5#:AE0[AD=VH?4G&4W53$973VQQQY]# %FQ?L9RQMD!^.N])%S^8
M%A6K2+]E7J/;KQ!.)8_PF_?B)!V_3'RKNWNVYN'?PQA^^_:%U_391\O>N]LB
M$_21?_X>B=E-?HIXUAK1F"4T18SZ&9+2_:%^E$/]U^_5@]:Z'DF5N*F6!4:6
M.3D".1)E(?39DN3AGJ+#F9RO-K.#4[XZ#POWLE^[ :H)E'S4[MT#8%=;@SKM
M1L6V/QJA;4)>_W@4H:Y/9H ==7W'-1^;!"XY"-_=-/9 H[6%"E2_>SQVMD88
M/ %AL/7=R"::.(5L=]J.M0/<1AK8$&O3MYD1@5/X0SH%4LEAD=,NN4PR%!+*
M8#0ABDO.34:+'V/,<8\[O\W[@18HA2Y;6*ZXPZO>3X6N$IOZ@%LCCNJ*5\).
MD(:\03;>R-^&K^C8[*=U#GQ>TE1*J-%UE1(Z'-!U'UM_#VHV8Z/U3C%+I:5$
MC<QZN^9YW;3FG%T09EJDR\9P+E*BL/8 ]92>&(,?7Q@.5( AU+,#3][)^?Y_
M[:$VA__Q+Y[M!!:WZ%7D37(!Z=EPE7Y=9HTX"?D/989TVCJ38CC G1B%)HB9
MT-J82S1PTFLK;)G<J4!EI*3S[YX^V1D.TNTK,">0,/Y=U6^3_;SE3)P1)8\_
MW7F<+/J>&('M-:$S\'?-5U%-' >7<UT5RRL4!Y@QAQ/'C-H+[2Z-;B]Q.-*+
M>_<TL5L:S,5S"<"$I[U$8P)3PT%G@^F,93V1(3C818MH+#UXGT\Y-:ETYP1_
M0I[S.B_?)B=@8=O0&3G#*?\HK=%=>I&6)N<._W21E5/,7)A.,[%/*ZK8F"_+
M:6OBF3P*\3N:U(BW_ZIJ6O*)(=.U1.T2\6/[WU1VSF/RWF[-1B0Q,.N![@[F
M)C1CB3OF-?(27 @G^Y.LCV?GDY] <X 4,V%GV2(C'H/'5J<@$+#XH^!40!CW
MHJI [,% (*6$:W#FH^@55^DO58TDFN/7X/.9XRBOZ^S!2XX4"..7&Z5#_WB:
M[)D&BK$A9]20PMQ""C781]%MD7')2_8.UB )#'R7K7=2^_9-@L276RRW6:3Q
M\3.@8**]I_A=D8;/DI^0 N#/?[Y I-X-LP_/DO/5 I:[6Z>3?/HL.4ZO,MZK
MXPIWX+$7-#1OX5_^U '-+T$[07^,4DS8#!ESYL7G5$Q$O !;_6V*R2S-@4.M
M%:J]*DNO3,4,Q(Y0_?1Z"J<+644E^9QZ"F:5_:X]_6!Z"F7:]6?0?#H]93CP
M%)7D\^DI8'AV%)7DL^@IPT&HJ"2?0T^QJ8=:44F^)#WECV39^NRA:]XF4D3@
M"P:FK0;I,'LW!1Y^P24-/1P3R>ZVRVQC \K&?,HZJ.5Y_+5#&9$/_OC?9X=8
MK0-W"'>'?I4VL_37Y/NBFH"F=$9$Z_$__X'(7Z3L4_]I.!#))'R%F,_=2I68
M4:K$CQENOSBZ#IT'\\VG3E+\7!6B,C)&WV$[#DSA320K^0WZG+V,DDCZ\11U
MK)CGS^4TNR0>*7G""@U7G"/:"Q=M[%ZXPLCA0/*KX*%IG6&VET1\T2&*>;7Q
MP*F@),PRSDVVOX?;0CY4\S;Y4G%%!QEY#RO8AO,:-LTNL;VLJ^7%)<AU^)X\
MA9_'8AZL(DFQD"C9AU>J60Z"IUD!E[C2\=^#GW?W?4 &K_3>:F,INX(QV,S^
M?-)6Y'LD#2A*#H)]=\015M*/2E<-"#+D IB4Y,!1QC&5 '&II=TZ76X9.36L
M;L0\LR8M^A[A([.'@\)\;Q1[$/DFD-=%3F+-?=9/GC,U>*+552CZRQ*LRFK^
M@![7M7PZ)$JY"X^^_AKV)(5%79'*'[K90U^R%.JYRG>8C*DY<55H' -AJ(XI
MF1^\N126E5J>H&J7U1/T./"#YK$R#0/\(7V.K;+7'Q2JNK6!"MG#VQ8D'%6,
M:0H=9K,:]\65)/FG(+.-UU59X6;R7/ 7\2HV/_8]YXI9?+V_P"\^KBM2#+;F
M-Y; _9ZY)%O6=E@+OI%8;AK6U&XS,S4CKRDYC)1)N9)1,HF1Z4I)>.9*!V M
M5$(SR6!/,J712E%'5?>$:(:#L&[4D-K:,JAQDM?R#C(?KRII[MVD[I!C+O"@
MG&"DJ$6ZXG1/DXG15RJH,WN%8J>V]*-S]PG]QL#JN*JJVTB7;=L/2WU.]PQW
M)E8'>#1G#FLKQ-*\:,+$7%6C+'1LLI&[G%AGUZZYXW%BQOTPA._+_D6Z\L>F
M;%(\!TI+*/)?ESE#><S2J_1"[!I*DD/;'LR;M&A7S/^R%&CN+X\("Z?+ &4!
M9#SYP6OGG&AM;D]_0M?&^3X@)_[R:(>L6LW1M@0+@6MDJ^0OC[O/F"J??-Y>
M=MDA3S^R-1,0'%RW-9W6RVSD=J7G&[ZZYO,>2;?2SVFI['*,1/((Z<#?IZ G
M-OX>1^.O,%%;[);:HMOA(&4%3@1%1ZW!P5[NGITC![BHTRMT#!2(Z9(V25!T
MB)]O.D:U3 J/;3O9%4 ;KC@=*[YL[B+L3G@9.[Y&FE1C+F_CGN=P-%9"(':$
MU'ZF/=Q@; X^5 R 18"2O@IKISKE^EV[L\'Q3#UDN9;!QLN)?7 3-H*!LU;P
MT[C+]UW!X%8S\OB#HA>_9N/1XZ=P7WM]>V;6T;*.,0L:L-2Y<LX-HB$'7)*;
M297LY$5V@3-\9N4H%DT5!,+"65"-L?.[@,HT1Y2(1C'6,=>0+RWJA9WB^!8N
MJTHG<2^!OW[]/AL50D>8E(MX>8S5$OIY.#\X#VL-I18R*HUM,>9'D<:3580Y
M^=.%Z^V*6T0WT%74.%?42U">**B1H%K;I=KV0)^X[?-Q7\)/T'1[P3VT!A[-
M]ED#M-<+4++]P0.&GR4"^>0^V.@'&Y_<!QL_O;NKZ^_"08P'?SB(>+N. I:C
MD JZF!!<.-51DL>F^ '+""6*D.HR>LKLM$@173[GN2'D6T84WF9FQ0T$T&#<
MRI,,67\Y-0H"PV594\Q5.-HB>/SULG3NO4 *(O<44S7 V1*![XW.6^I%@D0C
M08UX.,"Y$4<V6:TJ+?"N.6R%A$]126\(FNZ4#DN*_8Y\SR(;C7!PSD,;\;**
M*_9V$S)>C,#X0;[Y&#5(QNSF]/Q^&O6#R(Z+ LD$"2R0NW;4UUS6"4>9E0U[
M=/%"[2U7#XY*RDAX"<>+,$2P93@H*"RRW^'!Q?A::8NGC=XO5X^Q\AQ*2VC=
M>R1&B5X?DL9ZTMA]-)"0^-))=8W 3%H!TZGR ?[86@59:[3$P9$(YV:GQ:8%
M90.W>[;,S.:E4PFL8\:W_-!U<G>@V3+G:Y#@O[+N0_ M4IZE$!V^C0[D25V]
M#7CS%F'= (%@+H"$T&G_[12=ZWOD&_\N3$*?1<$_S^LKY2JW,#3C-7B/1N1@
M" ,(MYGSR"10TB3B_X\'&3KN[K1D-P*Z3-B*H*JRA:EF<@ZA5+D!^,($T,N6
M$_G>+(RLH$=+7%@1<F4T%[H&%+E'R#&:I\&!#':2T9 "3&17$S<<N*U&JY29
M>F.^/[)Q@9[=;BH59$.TAFS6V#)*09[1I=)7B.*T*%:X<>CO=)Y-.IU8(8K>
MI9M4D6"O]S&G#/Q2+JF]PPX<LN5J  $2Q&) ON.48XRU+_;DFPQU E3Z$6<'
M9UU+1,-#18(U D\5Z*S4E3I*!&%OL_)3="!1T(Q=KQZ.D-+&R 4%>W -A P_
M]D9L\.@D:<.OM1&#];("XT0J_@3?@3@)GYHQDX%"O"2/A)"EF(O(,J)@>E@-
M&$QHRT,K"V85QAE$"&<SXA%RT#9S1=T(M_X^CN#*F9S>+.4@EZD/H=6R'$.O
M>I$;A%ID=!X,O8JAV'-7W@Q&5,K>I?"1S$HLF;(#+_,F"3,C]V+\PB),R"-V
M3*.DJQ@5E#D+S1&#?LJ)AMB2V16A[?86;-'2\%'K6R'.R -N2NPT,4*/'W-Y
M]G# *8_$RH0^XF73!(2+0K;+!D- OM3CUNRA]Y#0)!; /B0_<'%38Y2_%$\8
MYF6A'6.C^ 8G-EUUE8T(J<N6$QH,,7YE4JEUC(U)XVH6##,4+TY1-0VY1S5<
M(2^#_#+60+.<W*JGI&9D6F7""Y-G@=*4:[Q^8FM%>B,(&[BYE%DF8L#!T#JG
M$$* S1"0F8N-.6@[18<T0I%R%D,Y>T@?_(5R]B@! *[-O,^O[$-,SYWZ*-=N
M%E<?UQ<>:I&@-3 R4JGZ4'#.[I@"S_K[<96\K%G_P4PN";?"H9U-ZWS!NC@\
M,W?/&"X*MPH?<:C52*C=Y^R-%8YJL:K[48=V&]%:@09JHQ6Z],J.WL6\6^5+
M^!@NEB]U-;$^9PAQ]((5A+'-:T$^(W6GJNF%SP18'2<L)SOW+KBCY9GV&5%\
M5-9#6%0-]Q@^,#-M.4BTP;D*,@YMS9TC8?8V[,/:+_![Y^D[#N"BZYLS4\6:
M5!E%843$T"?B2ULV-Z5/!NS>1+=9.>3D2C8DV_2=M5N0:Y)+"&,DDB ;D10Z
MR2D2 QT;5%BA=K,REW*[+M-V[# =XM6U[CZNSP&2^\)_K>E?[.UCD"1GP%6G
M*D>.WWR&AV("-G@ 8_S%976#$%WT,Z/V!\#JI(=%(L$<UW+3364ZK5?>T%U
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M30.C.Y093VO^?.U7O^S&K]_<IWOXZ1[?W*=[?($$34D$<VDE*Z[*_=3F+'O
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MBQ\*JBIQT\6M&P[60#Y$-U\S)74-+8W>9F2QBET(54M4R.\D<DFEX;:!9"J
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MH)W<C MOVDO,</C'@__47>@\=)[AP*?7")9X,EM:=$-!GH2;!5KYE-ITE=W
MJ]?@+@10D>T0^&7@(A<$ B*!%7DULXVGT?/@RA_Q?KW#?LNX0ZXG-1/=W;+5
M&1'W)ZN:.%-U.-A;&=IBZ^!<$1MNJ"Z%4:=+P*2=;%Z53H3RW"38X'51!IS)
M\N$&8^R7H6"?09(-[$T#\,)9@Z9KM= 7?I/FQHXBE:AHZ@_V*LQ;@><.*..]
MZJK12E4@P27MOF)17O/*=5X5:6L >:7C FNL,'J)T<@B:+9PMVCN4E"8K<5&
M(1L'WZ,NMI$>/>C572A4:11;@M* *5'?[8Q8B[0M#!4<ZYH4<[&]QI%\+4=<
M\QQ43*#-K4??C%PQ P_G9R'2H!3MX])N32[P:W03H5*4705I%"AS<, (SJJV
M>#FS![Z=6A7^-;S$*? V?9]O#*A3RVB65-6/Z$H(DN1,6*1\<5R:+E\2PAHS
MEDR&B%Y7*76,NH$?MHQSU#,OQAJHT;J(X8MDS>#V6@A5T$N65+4^(HT-9T+J
M.*DWN4HJ59COJ)UQ9EXD&DK'3'->MU>?HPSR2X)5_7K;=9%&'57HX:[BJIJ]
M$.Q>X5=GKKM\B(!.DLD9K %>K[4?IICZR6$8IXNHLH"OMQ_9R]DIQ1DG?J*I
M*;L4N\JE/MY:5D6N((6=S%\8L3EFEXZ*/QG"52%MY\B-8]K(-"2F8WUGA)$[
M"5AAI#H+Y:WDL&(WN8N2.W5<\#*]EI8N0]=5?X9#<K: 2]D51L%,H6V!RV2S
M1.JG9\N"TN6F2U6=Z/?-IGF0-MZ"HE!FG/PQ7Y8S+^Q.24<K5HRLF=FF[Q0P
MK?6*7'&BJ5%XS?.2%,EIH'9#J1]M/K<6C&2""DAAS/,CZZ%YBOF$\J2$VV%.
M!9:C<;O)$9]>V5/AS<W8/)/_YDZTN@^4M%UG*TT02\6;I7]NG+7E<K%4@C4*
M$U?*J](1&0S,>(#H$9+$>B&2OVTMC'AG&%(6FLJL949^S9G_2! HT3T](_:/
M.Q_O(T&:D&@E[27"QV\]&>DF]HTM3_(=&XH"Y? ::KKDZ)TH.4Q(HC]WVQ25
M! J*"]!*>3YWK1K-GC#DF:L#P!N"\Q^;MI.N_06ERN,I7/K=.U61<QC,,:P'
M)#"7G>M#Y.#IG9$MFR>=_.,^Z<1/.OG'?=+)%TC0"J?UV%WKQG@/M)YB6MCF
M[$4C1QG!EXOSG3V65C:1R$2/#>;[$6<W'34$4QJ/M"' XYA:$:@/* 6-_F"\
M^"2:;!,H%(*-"$XMP6P,0+$M[;$V3?68E6ZH2*S7(JT:"&KH6.KEM';A]P2F
M,-.U\F<:4&&WQ0IG*:HOL$PT3MJU^H+U3'=*KO2#XLR/''6DXDP[88>#79A6
MV* .E2=9>Z,A$%3V\\R@8<'?<R!B8&%'I$38-GNNL0O2+F@RA?%0J458_Z$M
MMNBM(+95J<Z7RJKEG9%F"G0OC/:)J73>H3C3]B;P%=)MYXB(H1[T,DMGZ  *
MA4D/4YHE9!946<8F8RL);.*YUGHE%F/0TYC1L .)(*$K^K?K#R4'#NF3V-12
M/L6#9O9S';NH87]3.J&0<,:(57;4;CC0JWZ5QTST)((C9YPMX@_AJ#J'@R0#
M#_XV(1\LPYX/![[C'0,8=5JO[A8ASSR3/SE5/<!\,"CR>.>.>/HMX)[\"YWR
MT-_%LO,U&_ZBQO593D?*CD1+<GZRF/*2]C1)ZNLT1\33Z>45=B$BW]P$:P6;
MMRMV<8BSSN_8)@V6WJOO&DF-6YO)22>P6)\[7][A;95WV)IU3AC)/%'.6P<I
M%>(PJH25+ 82V<U]'7OMG=I.XK\1]M]L_[W?YW.W;F(FT0)/^V,98*IU7'C*
M<#N1$8PW9<W8B@!'Y4.LWKGD+=>1SV&BA$6-"L(F1+4<#@@AWX"WZJ274$7H
MPLXP?@V5@]R4MN88YX<."_%X7>>PLXSZA$\[9H\N)+I665&X&&@PN@F-I75K
M0^C D218Y=*^@ILOKZVY]GC3;2]PK\\&WN)&\R-2UC!HX6$0^2/>W2YFWVPG
M/^8->IHX>G]7_>Q@X4L-%_!/U>EV..!.Z"8$_"PYQA8>;5M(B[\RV4^;2V=M
MNM2#*I,X(6<I:!XNUM1U1??(9%S:5B\N>Z8V<T+K465>AAYL+U\M5-32'A__
M8U XMC"JY5(68AD*ZHTGH(+\K/WX-N L&558]N#6:.H,0ZY0.K2Q3J]44WT>
M:YGR&%7]JM8@7!R.$W]TO-&*+),XF_^[ZY&D7U!XH:PD .R@@@/H[;RQT7[&
MV,$Z=%-4R0YC;<4&RX[@6F0=M=RF"H7=W+G)B1$HK(BIN9%"IO.,2C@_VIN&
MB-6#L C5.M1SU*-2><X4B/K.W6(([$MZ537P)1#O<U"*#U K7$I9*NS6CR
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ML1OW9Y;0ATRUL# E4U;8.SGA?0$8N& IAXG4G)DV6];9<- S2X+:^U/PER?
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MQ7Z11#U315OH%@W(:),-4Q40'( U@(Y2C1;SF<^99(EW\UB"FCPDQ?/@/92
M>K>P]-AN,@.( T*GVR% D Q"S2B?(,U9Q,4SKSWN,.-;.0#N9SR&5R@]46ZA
M&M2$)EJ=(0$!-L0G@%DC]$/Q3 KBZC6>O *D:O!"W$4<RP.5EO]<)XQ,P?9;
MM6[IZK#;9,HB#(@DV!W 3ZG\H#\@%8-N62C0'+^AJ<?^H3D>"LUQT- <OP>:
MY2L/!)J3-S3UQ#\T)T.A.0D:FI-W02,[WNM8,Y,?;\62O]H>S@:57I!I6[4"
M<Y"%ATO+6Q\L*D"M9U2(3TSRA=6MN!/\)6$1O&2&Y%Z  4Q;J3&TX:%C-]C'
M3[4@UG%>QYIB4=[[)=$R/Z-,TZ1]B"DTX4'2--8[N!1JGTC<\33#]-_)<^>)
MN%WL!0^K82LD#65XJ-CL]0%3Q" 9Y./$NL15W="PODIFE+M[!=ABZ_ *<*TP
M" ALCMJO !=73PJ1ZVY6C J"@1&A6>RLDRVFJCZNE871Q6U#K1[.O]=2X^.+
MK+*[T+M'SN '!-H25ST-F=.];98'T>. *;/7<QG*=9ZNQJL,$ZE]^*Z5.9O9
M33O51*X+@NA=TTUKFM;ECGOS-Y%D<L\SOMEL67F7Q_;<(*!SU<N=-G6/6T5!
M]'Z7,Y.$4HN:8L=8+#A-HB1+V/I7>?(I$FQKE4WD"@C8H*:AK0@"!="6R<%!
MB+32,01W@B@(B>R(_"5 E5A(W#X\6&?[+K$K*/H-:SA@91"0]-HS89$!XZ@6
M@8H0E,?XQ6:>IELBW@2/)<030J!Y *26/D2<().]4!6!/ME:D&@KY\?]]'BU
M3#)J.[EL2YS-28"Y:D8RRH-@ S!ELI"7(?Z IL=_6_T=Z2C'W7_#EP*KW+&+
M_6;%*9!]RJIR!4&'1<V!11($"K ODX8;CDHI*K0^LE,US%J:8Y2[ L!J2W=]
MHS"(3K<Y:GWY&WWM:<B_W$6/TA0!7DBPRUP/_3:3YO!?UP2!0(>QUDE)*45:
MZ^.%A,.4M>Y?!*R]+0+6/8N =8B+@/701<#:VR) [[9($2+'I=L53=882$[8
MJ78-18=EDP^+-"A48'_@F%&%H$.,ZXR6>8HSE9Y?;/+]7\D/EE8".F<Y+;ML
M5DDM;:(@&.ERUDIK622=JXF14KOF8ALG&8D+,U<)PRQ*,*W2(]JNB/>'.*-E
MH/D*G!Y]& P-,]G"J0C3N0RKP$.J2]>7THL','XCE/["^"M;$)QR1N+B6HKM
M3E&WWNT3,SVVFP_- .(@<!KB$'AT1@6-GU04TF'EE3 O)'WC=,LR+/)WR85M
M9 )T;LD!;#:),40!D6)W!A!2B5&A]O."=I$]HEID%;\[!#80DCM^7;O3M/'6
MME4;$#.=!J%WN,N<'X>U<1'EZ17+C*C?BTA>R!><X=(;V%Y([OJERB[3YMN4
M-FU "'4:!-^?K&)4JABLF?*6,D;,Y%)KS3N>$C=4[A/'M"RV<\=4DH#PL/GJ
MR" CD-9Z86&QP91^WJ8)(RD\$1DJMRQ8+399:$@"8L'F"V AER*M]<+"Y8:(
MM9S>?A;\-7LL\[.";0/4;MGHM-QDQ"H-B)4N?P S.@05,3JEKA]X=H>$XD66
M1;BE%JEC;$"S!C,M74C 0.9:M% 2J>LM-SQ#2XZ^I@1ECP1=EC]#5\\$7]3C
MZY=&HDB]$%&LREF,A0VA+K'S7QT!#;=^>Z2E# *D7GOP[Y!4$4B'.*;F5C(L
MZN=QN8EY1C;@VP[](:X(&FI><]2G#X*F@29-IO*PYLEU'HA4I,]L1O7D]O 2
MKR%RO#*V&#06QC5%$(R MJ!E<?VW OSDSMNN:!)=48[AJRP-C>.,>6U[1K*\
M@R @ MJNH!1YN1#E2B_]_QFS)[%]SJ+]G> 1(>HIJ[0:K?JNOPV,=LO,FYK4
MI&E0:$"<O<4O0."A"E2KXT-MQO)Y,4\]-*ZRN?'H:?&(Y0&\W6:IFD&E,?@J
M>&>0X]L+ QI@W&3HB @(O0$VH1L.>23*0S^@(AC5HCV=GZ6'+( D_KR_)P]$
MJ/<.EF27?98[>NHXPQ@0Z_KL;7!SS).YWL @('RK6^A4+T7U"M!*/2-65H%^
M5Y6@O!;;[Y?7-UW+3W*SWB3_6N&4R"W_!5!+ P04    " #GBRA;FS,[$5H'
M  #55P  %    '1B:"TR,#(U,#DP,E]P<F4N>&ULS9Q-<]LV$(;OG>E_8-6S
M+$MNTUJQF[$5*Z.)$[N6D[2]9" 2DC & 0T 6M*_+T"*BCX(<'WAV@=;IA;
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M(DP7G2-=M_: >T%M\8W[Y5[":H_\#U!+ 0(4 Q0    ( .>+*%MV5HH MQP
M /"&   5              "  0    !E83 R-38T,C@M.&M?8G)A9RYH=&U0
M2P$"% ,4    " #GBRA;_#)A. +1  !)-P0 &@              @ 'J'
M96$P,C4V-#(X,#%E>#$P+3%?8G)A9RYH=&U02P$"% ,4    " #GBRA;F@/*
MIL5>   R)0( &@              @ $D[@  96$P,C4V-#(X,#%E>#$P+3)?
M8G)A9RYH=&U02P$"% ,4    " #GBRA;.K.Y5]M.  ""D0$ &0
M    @ $A30$ 96$P,C4V-#(X,#%E>#0M,5]B<F%G+FAT;5!+ 0(4 Q0    (
M .>+*%MX7/1/* ,  .(+   0              "  3.< 0!T8F@M,C R-3 Y
M,#(N>'-D4$L! A0#%     @ YXLH6WRC3L#]"@  ?X8  !0
M ( !B9\! '1B:"TR,#(U,#DP,E]L86(N>&UL4$L! A0#%     @ YXLH6YLS
M.Q%:!P  U5<  !0              ( !N*H! '1B:"TR,#(U,#DP,E]P<F4N
9>&UL4$L%!@     '  < W $  $2R 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea0256428-8k_brag_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tbh-20250902.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903595</identifier>
        </entity>
        <period>
            <startDate>2025-09-02</startDate>
            <endDate>2025-09-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-02" id="Fact000004">0001903595</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-02" id="Fact000010">2025-09-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-02" id="Fact000011">Brag House Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-02" id="Fact000013">001-42525</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-02" id="Fact000014">87-4032622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-02" id="Fact000015">45 Park Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-02" id="Fact000016">Montclair</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-02" id="Fact000017">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-02" id="Fact000018">07042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-02" id="Fact000019">413</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-02" id="Fact000020">398-2845</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-02" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-02" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-02" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-02" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-02" id="Fact000025">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-02" id="Fact000026">TBH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-02" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-02" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-02" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
